<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-eli-lilly-diabetes-drug-wins-fda-approval-030511/</loc>
		<lastmod>2011-05-03T03:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hatchtech-recruits-first-subject-in-deovo-phase-2b-trial-030511/</loc>
		<lastmod>2011-05-03T05:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/microdose-receives-milestone-payment-under-novartis-pact-030511/</loc>
		<lastmod>2011-05-03T05:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioniche-life-sciences-opens-new-canadian-vaccine-manufacturing-facility-030511/</loc>
		<lastmod>2011-05-03T06:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark-fluticasone-propionate-005-lotion-gets-fda-approval-030511/</loc>
		<lastmod>2011-05-03T07:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approval-for-intellipharmaceutics-seroquel-xr-generic-version-anda-030511/</loc>
		<lastmod>2011-05-03T07:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tafluprost-reduces-intraocular-pressure-merck-phase-iii-study-030511/</loc>
		<lastmod>2011-05-03T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hebei-aoxing-naloxone-sublingual-film-receives-chinese-patent-030511/</loc>
		<lastmod>2011-05-03T07:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tcgrx-introduces-medpickrx-050511/</loc>
		<lastmod>2011-05-03T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gls-sciences-introduces-glucalite-for-healthy-blood-sugar-060511/</loc>
		<lastmod>2011-05-03T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perrigo-q3-net-sales-rise-24-040511/</loc>
		<lastmod>2011-05-03T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ajinomoto-to-sell-sports-nutrition-products-online-100511/</loc>
		<lastmod>2011-05-03T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/catalyst-rx-introduces-new-mobile-platform-040511/</loc>
		<lastmod>2011-05-03T23:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-q1-revenue-marginally-falls-040511/</loc>
		<lastmod>2011-05-04T00:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hikma-pharma-acquires-multisource-injectables-business-of-baxter-040511/</loc>
		<lastmod>2011-05-04T00:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seavan-to-manufacture-alda-pharma-products-040511/</loc>
		<lastmod>2011-05-04T00:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pro-pharma-chooses-safc-as-davanat-manufacturing-partner-040511/</loc>
		<lastmod>2011-05-04T00:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-revenues-up-12-in-q1-040511/</loc>
		<lastmod>2011-05-04T01:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/isconova-acquires-nordic-vaccine-assets-040511/</loc>
		<lastmod>2011-05-04T02:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meda-pharma-introduces-5ml-nasal-spray-for-rhinolast-allergy-040511/</loc>
		<lastmod>2011-05-04T03:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/debiopharm-yale-university-sign-licensing-pact-040511/</loc>
		<lastmod>2011-05-04T04:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regenx-biosciences-gets-28m-nih-grant-040511/</loc>
		<lastmod>2011-05-04T05:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arca-biopharma-signs-global-rights-agreement-with-novartis-040511/</loc>
		<lastmod>2011-05-04T05:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo-fisher-adds-new-aa-spectrometer-to-ice-3000-series-range-040511/</loc>
		<lastmod>2011-05-04T05:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anthera-pharma-q1-net-loss-widens-040511/</loc>
		<lastmod>2011-05-04T06:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cimzia-improves-signs-and-symptoms-in-ra-patients-ucb-040511/</loc>
		<lastmod>2011-05-04T07:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-pharma-q1-revenues-surge-040511/</loc>
		<lastmod>2011-05-04T07:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lorus-therapeutics-receives-us-patent-for-cancer-drug-040511/</loc>
		<lastmod>2011-05-04T07:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/akebia-concludes-ckd-drug-phase-2a-trial-040511/</loc>
		<lastmod>2011-05-04T07:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/molecular-templates-alnylam-in-rnai-drug-delivery-research-collaboration-060511/</loc>
		<lastmod>2011-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dabur-india-acquires-ajanta-pharma-otc-energizer-brand-30-plus-060511/</loc>
		<lastmod>2011-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aptuit-to-manufacture-phase-iii-lower-dose-nsaids-for-iroko-pharma-060511/</loc>
		<lastmod>2011-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axios-to-supply-trackable-pallet-software-technology-to-elba-labs-060511/</loc>
		<lastmod>2011-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heska-inks-deal-with-rapid-diagnostek-050511/</loc>
		<lastmod>2011-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioclinica-q1-revenues-up-050511/</loc>
		<lastmod>2011-05-04T23:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-aventis-mmv-sign-malaria-research-pact-050511/</loc>
		<lastmod>2011-05-05T04:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nycomed-almirall-sign-copd-drug-commercialization-pact-050511/</loc>
		<lastmod>2011-05-05T04:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/selexys-pharma-starts-recruitment-in-selg1-phase-i-trial-050511/</loc>
		<lastmod>2011-05-05T04:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cephalon-q1-revenues-surge-050511/</loc>
		<lastmod>2011-05-05T04:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/molecular-partners-licenses-retinal-diseases-drug-to-allergan-050511/</loc>
		<lastmod>2011-05-05T04:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/labopharm-q1-revenue-climbs-050511/</loc>
		<lastmod>2011-05-05T04:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-to-donate-nanodrop-1000-spectrophotometers-050511/</loc>
		<lastmod>2011-05-05T04:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/savient-pharma-files-chronic-gout-drug-maa-with-ema-050511/</loc>
		<lastmod>2011-05-05T04:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/polish-approval-for-cel-sci-head-neck-cancer-drug-trial-050511/</loc>
		<lastmod>2011-05-05T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intercell-names-new-ceo-050511/</loc>
		<lastmod>2011-05-05T05:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alliqua-files-with-uspto-for-transdermal-delivery-technology-patent-050511/</loc>
		<lastmod>2011-05-05T05:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/metabolon-receives-us-patent-for-metabolomics-methods-for-drug-discovery-050511/</loc>
		<lastmod>2011-05-05T07:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sbio-regains-jak2-program-full-rights-from-onyx-050511/</loc>
		<lastmod>2011-05-05T07:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/burkert-bbs-develop-new-process-application-050511/</loc>
		<lastmod>2011-05-05T07:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quotient-clinical-upgrades-nottingham-clinical-facilities-050511/</loc>
		<lastmod>2011-05-05T07:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-pain-drug-060511/</loc>
		<lastmod>2011-05-05T23:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovista-receives-grant-for-rd-in-personalized-medicine-060511/</loc>
		<lastmod>2011-05-05T23:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mmrf-apgd-sign-relapsed-multiple-myeloma-drug-development-pact-060511/</loc>
		<lastmod>2011-05-05T23:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-afinitor-tablets-for-advanced-pancreatic-net-060511/</loc>
		<lastmod>2011-05-06T01:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ista-pharma-revenues-surge-in-q1-060511/</loc>
		<lastmod>2011-05-06T02:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xoma-q1-revenues-up-060511/</loc>
		<lastmod>2011-05-06T02:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-revenues-fall-in-q1-060511/</loc>
		<lastmod>2011-05-06T03:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/coti-looks-for-new-partner-to-develop-hiv-integrase-inhibitor-scaffolds-060511/</loc>
		<lastmod>2011-05-06T03:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-to-resolve-1000-avandia-lawsuits-060511/</loc>
		<lastmod>2011-05-06T05:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novozymes-introduces-albufuse-flex-technology-060511/</loc>
		<lastmod>2011-05-06T05:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/selvita-signs-definitive-agreements-with-investors-in-poland-060511/</loc>
		<lastmod>2011-05-06T06:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/yaupon-names-new-ceo-090511/</loc>
		<lastmod>2011-05-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/unigene-q1-revenue-falls-marginally-090511/</loc>
		<lastmod>2011-05-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enzon-pharma-q1-revenues-nosedive-090511/</loc>
		<lastmod>2011-05-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/life-technologies-agrees-to-supply-dynabeads-to-epigenomics-090511/</loc>
		<lastmod>2011-05-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivation-q1-net-loss-narrows-090511/</loc>
		<lastmod>2011-05-09T01:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mithridion-psp-drug-gets-fda-orphan-drug-status-090511/</loc>
		<lastmod>2011-05-09T01:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cephalon-nuvigil-tablets-show-positive-results-in-phase-iv-trial-090511/</loc>
		<lastmod>2011-05-09T02:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-receives-eur2m-milestone-payment-from-boehringer-090511/</loc>
		<lastmod>2011-05-09T03:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merrimack-pharma-takes-over-mm-398-european-asian-rights-090511/</loc>
		<lastmod>2011-05-09T03:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heptares-licenses-shire-adenosine-a2a-antagonist-worldwide-development-rights-090511/</loc>
		<lastmod>2011-05-09T05:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gtx-q1-revenues-fall-090511/</loc>
		<lastmod>2011-05-09T06:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/polypid-introduces-new-family-of-drug-carriers-090511/</loc>
		<lastmod>2011-05-09T07:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bal30072-effective-against-superbugs-basilea-090511/</loc>
		<lastmod>2011-05-09T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alkermes-to-merge-with-elan-drug-technologies-090511/</loc>
		<lastmod>2011-05-09T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-idec-swedish-orphan-biovitrum-to-initiate-rfixfc-global-pediatric-trial-090511/</loc>
		<lastmod>2011-05-09T08:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas-medivation-treat-first-patient-in-prostrate-cancer-drug-phase-2-trial-090511/</loc>
		<lastmod>2011-05-09T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novavax-q1-revenues-up-090511/</loc>
		<lastmod>2011-05-09T08:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/netsmart-appoints-new-ceo-100511/</loc>
		<lastmod>2011-05-09T18:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/trial-by-fire-solutions-to-deploy-simplectms-in-pearl-therapeutics-100511/</loc>
		<lastmod>2011-05-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orexigen-q1-revenues-soar-100511/</loc>
		<lastmod>2011-05-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antares-pharma-revenues-up-in-q1-100511/</loc>
		<lastmod>2011-05-09T23:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cimzia-offers-relief-in-ra-patients-ucb-100511/</loc>
		<lastmod>2011-05-10T01:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-pharma-revenues-surge-in-q1-100511/</loc>
		<lastmod>2011-05-10T02:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scolr-pharma-q1-revenues-increase-11-100511/</loc>
		<lastmod>2011-05-10T02:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sartorius-stedim-biotech-unveils-univessel-su-100511/</loc>
		<lastmod>2011-05-10T05:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-healthcare-regorafenib-gets-fda-fast-track-status-100511/</loc>
		<lastmod>2011-05-10T05:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caprotec-bioanalytics-closes-eur1m-series-b-financing-100511/</loc>
		<lastmod>2011-05-10T06:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phylogica-pepscan-form-research-pact-100511/</loc>
		<lastmod>2011-05-10T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/optimer-presents-cdi-drug-phase-3-trials-data-100511/</loc>
		<lastmod>2011-05-10T07:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-pronova-release-hypertriglyceridemia-drug-phase-3-trial-results-10511/</loc>
		<lastmod>2011-05-10T07:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/resolor-improves-bowel-function-in-women-shire-100511/</loc>
		<lastmod>2011-05-10T07:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/interleukin-genetics-metagenics-in-weight-management-drug-collaboration-130511/</loc>
		<lastmod>2011-05-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jdrf-amylin-pharma-ink-research-pact-110511/</loc>
		<lastmod>2011-05-10T23:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott-ulcerative-colitis-drug-phase-iii-trial-meets-primary-endpoint-110511/</loc>
		<lastmod>2011-05-11T00:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimmune-gets-access-to-pfenex-expression-technology-110511/</loc>
		<lastmod>2011-05-11T00:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allos-mundipharma-to-jointly-develop-folotyn-110511/</loc>
		<lastmod>2011-05-11T01:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medidata-solutions-q1-revenues-surge-110511/</loc>
		<lastmod>2011-05-11T01:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pepid-introduces-duplicate-therapy-checker-110511/</loc>
		<lastmod>2011-05-11T01:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei-takes-over-loramyc-development-rights-from-bioalliance-pharma-110511/</loc>
		<lastmod>2011-05-11T02:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/progenics-pharma-q1-revenues-up-110511/</loc>
		<lastmod>2011-05-11T03:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/psivida-q3-revenues-fall-110511/</loc>
		<lastmod>2011-05-11T03:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-sega-drug-gets-swissmedic-approval-110511/</loc>
		<lastmod>2011-05-11T05:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emd-millipore-establishes-new-facility-in-china-110511/</loc>
		<lastmod>2011-05-11T05:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-fluzone-intradermal-vaccine-receives-fda-approval-110511/</loc>
		<lastmod>2011-05-11T05:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nymox-pharma-to-start-patient-recruitment-in-bph-drug-trial-110511/</loc>
		<lastmod>2011-05-11T05:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-submits-vemurafenib-nda-to-fda-110511/</loc>
		<lastmod>2011-05-11T05:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sistemic-roslin-cells-ink-mou-110511/</loc>
		<lastmod>2011-05-11T05:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apotex-restarts-oral-solid-dose-products-shipping-to-us-110511/</loc>
		<lastmod>2011-05-11T06:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovio-pharma-q1-revenues-climb-110511/</loc>
		<lastmod>2011-05-11T06:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/halozyme-viropharma-sign-licensing-agreement-110511/</loc>
		<lastmod>2011-05-11T07:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adia-nutrition-to-launch-chewable-probiotics-120511/</loc>
		<lastmod>2011-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ema-accepts-clinuvel-pharma-scenesse-filing-120511/</loc>
		<lastmod>2011-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanobio-starts-cold-sores-drug-phase-3-trials-120511/</loc>
		<lastmod>2011-05-11T23:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-effrx-pharma-ex101-nda-120511/</loc>
		<lastmod>2011-05-12T00:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/syntaxin-selects-synco-bio-partners-as-sxn101959-manufacturng-partner-120511/</loc>
		<lastmod>2011-05-12T00:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-insys-fentanyl-sl-spray-nda-120511/</loc>
		<lastmod>2011-05-12T01:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lannett-q3-net-sales-down-120511/</loc>
		<lastmod>2011-05-12T02:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovest-completes-biovaxid-manufacturing-site-construction-120511/</loc>
		<lastmod>2011-05-12T03:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china-pharma-revenues-up-20-in-q1-120511/</loc>
		<lastmod>2011-05-12T04:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pbs-biotech-introduces-single-use-bioreactor-system-120511/</loc>
		<lastmod>2011-05-12T04:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/biofocus-astellas-pharma-in-cns-drugs-discovery-agreement-120511/</loc>
		<lastmod>2011-05-12T05:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oasmia-pharma-licenses-paclical-to-medison-in-israel-turkey-120511/</loc>
		<lastmod>2011-05-12T05:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/almac-expands-biocatalysis-business-with-selectazyme-120511/</loc>
		<lastmod>2011-05-12T05:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schreiner-medipharm-launches-multi-functional-labels-for-autoinjectors-pens-120511/</loc>
		<lastmod>2011-05-12T05:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verona-pharma-starts-asthma-drug-phase-ii-trial-120511/</loc>
		<lastmod>2011-05-12T05:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ironwood-pharma-q1-revenue-climbs-120511/</loc>
		<lastmod>2011-05-12T06:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytheris-centre-lon-brard-immunid-initiate-breast-cancer-drug-phase-ii-trial-120511/</loc>
		<lastmod>2011-05-12T07:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dainippon-sumitomo-pharma-antipsychotic-drug-fails-in-study-120511/</loc>
		<lastmod>2011-05-12T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cornerstone-q1-net-revenues-down-120511/</loc>
		<lastmod>2011-05-12T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/naurex-completes-18m-series-a-financing-for-antidepressant-drug-phase-ii-trial-120511/</loc>
		<lastmod>2011-05-12T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neogenix-neo-301-antibody-to-receive-european-patent-120511/</loc>
		<lastmod>2011-05-12T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-selects-aegis-discoverant-for-product-scale-up-production-130511/</loc>
		<lastmod>2011-05-12T18:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/episys-ultimate-labelling-system-to-assist-barts-and-london-trust-130511/</loc>
		<lastmod>2011-05-12T23:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rapidscan-selects-ge-healthcare-as-rapiscan-distributor-in-uk-germany-130511/</loc>
		<lastmod>2011-05-12T23:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elan-licenses-pain-product-to-paladin-in-canada-130511/</loc>
		<lastmod>2011-05-13T00:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myhumana-mobile-app-makes-easy-to-manage-prescription-costs-humana-130511/</loc>
		<lastmod>2011-05-13T00:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tranzyme-pharma-q1-revenue-surges-130511/</loc>
		<lastmod>2011-05-13T01:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsion-net-loss-narrows-in-q1-130511/</loc>
		<lastmod>2011-05-13T01:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-pharma-h-lundbeck-start-mdd-drug-phase-iii-trial-130511/</loc>
		<lastmod>2011-05-13T02:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cell-biosciences-takes-over-brightwell-for-9m-130511/</loc>
		<lastmod>2011-05-13T03:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei-activus-pharma-sign-pact-with-toa-pharma-nitto-medic-130511/</loc>
		<lastmod>2011-05-13T05:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-rockwell-medical-anemia-drug-packaging-130511/</loc>
		<lastmod>2011-05-13T06:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ziopharm-oncology-files-ind-application-with-fda-to-start-melanoma-drug-study-130511/</loc>
		<lastmod>2011-05-13T06:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/threshold-q1-net-loss-widens-130511/</loc>
		<lastmod>2011-05-13T07:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-the-university-of-manchester-astrazeneca-establish-mccir-130511/</loc>
		<lastmod>2011-05-13T07:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china-sfda-approves-tianyin-pharma-anti-diabetic-drug-130511/</loc>
		<lastmod>2011-05-13T07:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sagent-pharma-q1-net-revenue-soars-130511/</loc>
		<lastmod>2011-05-13T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuvo-research-acquires-zars-pharma-160511/</loc>
		<lastmod>2011-05-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pacira-pharma-exparel-phase-3-study-meets-primary-endpoint-160511/</loc>
		<lastmod>2011-05-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intermune-reveals-ipf-drug-two-phase-3-trials-results-200511/</loc>
		<lastmod>2011-05-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ivax-diagnostics-net-revenues-decline-160511/</loc>
		<lastmod>2011-05-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-pharma-introduces-schizophrenia-drug-160511/</loc>
		<lastmod>2011-05-15T23:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-pharma-rolls-out-muscle-relaxant-drug-160511/</loc>
		<lastmod>2011-05-15T23:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-cautions-against-extenze-counterfeit-products-160511/</loc>
		<lastmod>2011-05-16T00:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cel-sci-starts-head-neck-cancer-drug-phase-iii-trial-in-poland-160511/</loc>
		<lastmod>2011-05-16T02:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-glenmark-in-crohns-disease-drug-development-agreement-160511/</loc>
		<lastmod>2011-05-16T02:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-agrees-to-acquire-57-stake-in-taiyo-pharmaceutical-160511/</loc>
		<lastmod>2011-05-16T03:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-idec-multiple-sclerosis-drug-receives-tga-approval-160511/</loc>
		<lastmod>2011-05-16T04:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-starts-recurrent-glioblastoma-drug-phase-ibii-study-160511/</loc>
		<lastmod>2011-05-16T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurologix-q1-net-loss-narrows-160511/</loc>
		<lastmod>2011-05-16T05:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac-biotech-sees-rise-in-q1-sales-160511/</loc>
		<lastmod>2011-05-16T06:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-victrelis-receives-fda-approval-160511/</loc>
		<lastmod>2011-05-16T07:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intelgenx-replies-to-fda-crl-160511/</loc>
		<lastmod>2011-05-16T07:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lotus-pharma-q1-net-revenues-down-124-160411/</loc>
		<lastmod>2011-05-16T07:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mwv-offers-machinery-modification-services-to-pharma-customers-160511/</loc>
		<lastmod>2011-05-16T08:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synexus-concludes-patient-recruitment-in-psoriasis-drug-phase-ii-trial-160511/</loc>
		<lastmod>2011-05-16T08:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/therabel-introduces-loramyc-in-germany-170511/</loc>
		<lastmod>2011-05-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uluru-q1-revenues-dip-170511/</loc>
		<lastmod>2011-05-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-pharma-introduces-bromfenac-ophthalmic-solution-009-170511/</loc>
		<lastmod>2011-05-17T00:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson-pharma-rolls-out-generic-amrix-170511/</loc>
		<lastmod>2011-05-17T00:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nutrastar-q1-net-revenue-rises-216-170511/</loc>
		<lastmod>2011-05-17T01:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-issues-noa-to-cleveland-biolabs-cblb502-cblb612-170511/</loc>
		<lastmod>2011-05-17T01:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drummond-group-certifies-csc-careveillance-clinical-surveillance-software-170511/</loc>
		<lastmod>2011-05-17T02:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cvs-caremark-to-introduce-pilot-epa-170511/</loc>
		<lastmod>2011-05-17T02:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china-shenghuo-sees-19-rise-in-q1-sales-170511/</loc>
		<lastmod>2011-05-17T02:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amylin-pharma-sues-eli-lilly-170511/</loc>
		<lastmod>2011-05-17T03:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-acquires-inspire-pharma-170511/</loc>
		<lastmod>2011-05-17T05:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/suppremol-in-licenses-interleukin-3-inhibitor-170511/</loc>
		<lastmod>2011-05-17T05:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acr-hybrid-score-improves-sensitivity-in-ra-patients-american-college-of-rheumatology-170511/</loc>
		<lastmod>2011-05-17T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astella-purchases-maxygen-equity-interest-in-perseid-therapeutics-170511/</loc>
		<lastmod>2011-05-17T07:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china-bct-q1-sales-revenue-up-722-170511/</loc>
		<lastmod>2011-05-17T08:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/swissmedic-approves-eisai-halaven-170511/</loc>
		<lastmod>2011-05-17T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-to-take-over-advanced-biohealing-180511/</loc>
		<lastmod>2011-05-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anavex-responds-to-new-alzheimers-disease-diagnostic-guidelines-190511/</loc>
		<lastmod>2011-05-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accumetrics-verifynow-receives-ce-mark-180511/</loc>
		<lastmod>2011-05-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zen-holding-to-purchase-millennium-healthcare-solutions-180511/</loc>
		<lastmod>2011-05-17T23:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tekmira-pharma-bristol-myers-squibb-widen-multi-year-collaboration-180511/</loc>
		<lastmod>2011-05-18T00:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-roche-to-jointly-develop-hcv-drugs-180511/</loc>
		<lastmod>2011-05-18T00:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-accelerates-crizotinib-regulatory-procedures-180511/</loc>
		<lastmod>2011-05-18T00:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/codexis-widens-pact-with-teva-pharma-170511/</loc>
		<lastmod>2011-05-18T01:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tga-approves-aurobindo-pharma-schizophrenia-osteoporosis-drugs-180511/</loc>
		<lastmod>2011-05-18T01:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gbi-rafagen-sign-manufacturing-agreement-180511/</loc>
		<lastmod>2011-05-18T01:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regency-therapeutics-daiichi-sankyo-introduce-sprix-nasal-spray-180511/</loc>
		<lastmod>2011-05-18T02:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-pharma-curetech-lymphoma-drug-phase-ii-trial-meets-primary-endpoint-180511/</loc>
		<lastmod>2011-05-18T03:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jll-partners-sells-pharmanet-development-group-to-inventiv-health-180511/</loc>
		<lastmod>2011-05-18T03:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ohr-pharmaceutical-receives-canadian-patent-for-ohravr118-preparation-190511/</loc>
		<lastmod>2011-05-18T03:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cel-sci-starts-head-neck-cancer-drug-phase-iii-trial-in-canada-180511/</loc>
		<lastmod>2011-05-18T04:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rapaflo-improves-urinary-symptoms-watson-pharma-phase-2-study-180511/</loc>
		<lastmod>2011-05-18T05:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lifevantage-q3-net-sales-up-270-180511/</loc>
		<lastmod>2011-05-18T05:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-xgeva-phase-3-trial-meets-primary-endpoint-180511/</loc>
		<lastmod>2011-05-18T06:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/erytech-pharma-teva-sign-agreement-on-graspa-180511/</loc>
		<lastmod>2011-05-18T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novozymes-biopharma-to-unveil-hyaluronic-acid-product-180511/</loc>
		<lastmod>2011-05-18T07:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-q1-revenues-climb-180511/</loc>
		<lastmod>2011-05-18T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytheris-citn-select-cyt107-for-clinical-trials-at-network-institutions-180511/</loc>
		<lastmod>2011-05-18T07:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vildagliptin-effective-in-muslims-fasting-during-ramadan-novartis-vector-study-180511/</loc>
		<lastmod>2011-05-18T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allon-therapeutics-updates-on-neuroprotective-drug-phase-23-clinical-trial-190511/</loc>
		<lastmod>2011-05-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/metabolex-starts-gout-drug-phase-2-trial-190511/</loc>
		<lastmod>2011-05-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinipace-worldwide-acquires-pfc-pharma-focus-190511/</loc>
		<lastmod>2011-05-18T22:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glycotope-recruits-first-patient-in-fsh-gex-clinical-trial-190511/</loc>
		<lastmod>2011-05-18T23:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/healthmark-introduces-tcgrx-medpickrx-in-canada-190511/</loc>
		<lastmod>2011-05-18T23:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmstar-acquires-cgmp-facility-in-wilson-190511/</loc>
		<lastmod>2011-05-19T00:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-axitinib-meets-primary-end-point-in-phase-3-trial-190511/</loc>
		<lastmod>2011-05-19T00:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mos-selects-medical-office-online-ehr-pm-solutions-190511/</loc>
		<lastmod>2011-05-19T01:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/afssaps-approves-txcell-to-extend-crohns-disease-drug-phase-iii-trial-190511/</loc>
		<lastmod>2011-05-19T02:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-tentatively-approves-perrigo-partner-synthon-levocetirizine-solution-190511/</loc>
		<lastmod>2011-05-19T02:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-pharma-to-acquire-nycomed-for-eur96bn-190511/</loc>
		<lastmod>2011-05-19T02:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qualitest-pharma-drugs-receive-fda-approval-190511/</loc>
		<lastmod>2011-05-19T03:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biothera-starts-colorectal-cancer-drug-phase-iii-trial-190511/</loc>
		<lastmod>2011-05-19T05:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tissuegene-commences-patient-recruitment-in-djd-drug-phase-ii-trial-190511/</loc>
		<lastmod>2011-05-19T05:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-releases-lung-cancer-drug-phase-ii-results-190511/</loc>
		<lastmod>2011-05-19T05:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synergy-outsourcing-partners-with-chemovation-190511/</loc>
		<lastmod>2011-05-19T06:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-reveals-olaparib-phase-ii-trial-results-190511/</loc>
		<lastmod>2011-05-19T06:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-repligen-sma-drug-trial-190511/</loc>
		<lastmod>2011-05-19T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/app-pharmaceuticals-gemcitabine-hci-for-injection-receives-fda-approval-190511/</loc>
		<lastmod>2011-05-19T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ssb-in-pact-with-raumedic-for-liquid-transfer-technologies-190511/</loc>
		<lastmod>2011-05-19T08:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shangpharma-q1-net-revenue-up-256-190511/</loc>
		<lastmod>2011-05-19T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bosch-packaging-technology-launches-gkf-2500-capsule-filling-machine-230511/</loc>
		<lastmod>2011-05-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transtech-pharma-establishes-high-point-clinical-trials-center-240511/</loc>
		<lastmod>2011-05-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo-fisher-plans-to-buy-phadia-200511/</loc>
		<lastmod>2011-05-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cel-sci-starts-head-neck-cancer-drug-phase-iii-trial-in-russia-200511/</loc>
		<lastmod>2011-05-19T23:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-pays-5m-in-isis-pharma-pact-200511/</loc>
		<lastmod>2011-05-19T23:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/unigene-in-contract-manufacturing-agreement-with-cara-200511/</loc>
		<lastmod>2011-05-20T00:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lincoln-pharma-introduces-anti-malarial-drug-200511/</loc>
		<lastmod>2011-05-20T00:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aska-pharma-signs-agreement-with-hra-pharma-on-contraceptive-drug-200511/</loc>
		<lastmod>2011-05-20T01:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iroko-cardio-selects-veeva-crm-200511/</loc>
		<lastmod>2011-05-20T01:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viropharma-commences-cdi-drug-phase-2-trial-200511/</loc>
		<lastmod>2011-05-20T02:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enterologics-partners-with-ust-for-probiotic-shelf-stable-formulation-200511/</loc>
		<lastmod>2011-05-20T03:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/infinity-pharma-commences-cancer-drug-phase-2-trial-200511/</loc>
		<lastmod>2011-05-20T04:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/japan-allows-takeda-to-change-cpp-drug-dosage-200511/</loc>
		<lastmod>2011-05-20T06:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-pays-75m-regulatory-milestone-to-auxilium-200511/</loc>
		<lastmod>2011-05-20T07:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-hcv-genotype-1-drug-receives-chmp-positive-opinion-200511/</loc>
		<lastmod>2011-05-20T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/akzonobel-builds-new-research-laboratory-in-deventer-240511/</loc>
		<lastmod>2011-05-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ampio-pharma-concludes-pe-drug-phase-iii-european-trials-data-analysis-230511/</loc>
		<lastmod>2011-05-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eliquis-receives-european-approval-230511/</loc>
		<lastmod>2011-05-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer-launches-pinaacle-series-atomic-absorption-spectrometers-230511/</loc>
		<lastmod>2011-05-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-hgs-benlysta-receive-chmp-positive-opinion-230511/</loc>
		<lastmod>2011-05-23T00:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/logos-technologies-partners-with-medidata-solutions-230511/</loc>
		<lastmod>2011-05-23T01:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-sutent-receives-fda-approval-230511/</loc>
		<lastmod>2011-05-23T01:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/serina-receives-us-patent-for-polymer-drug-delivery-technology-230511/</loc>
		<lastmod>2011-05-23T01:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-grants-positive-opinion-for-vibativ-astellas-theravance-230511/</loc>
		<lastmod>2011-05-23T02:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-releases-emphasis-hf-trial-pre-specified-sub-analysis-results-230511/</loc>
		<lastmod>2011-05-23T02:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei-to-introduce-emergency-contraceptive-pill-norlevo-in-japan-230511/</loc>
		<lastmod>2011-05-23T03:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china-ruitai-sees-fall-in-q1-sales-230511/</loc>
		<lastmod>2011-05-23T04:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tibotec-hiv-drug-receives-fda-approval-230511/</loc>
		<lastmod>2011-05-23T04:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pieris-unveils-preclinical-results-from-prs-080-hepcidin-antagonist-drug-program-230511/</loc>
		<lastmod>2011-05-23T05:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-issues-warning-letter-to-aurobindo-antibiotics-manufacturing-unit-230511/</loc>
		<lastmod>2011-05-23T06:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vectura-q1-revenue-increases-230511/</loc>
		<lastmod>2011-05-23T06:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-idec-fampyra-receives-positive-opinion-from-european-medicines-agency-230511/</loc>
		<lastmod>2011-05-23T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-gets-japanese-approval-for-pediatric-drug-230511/</loc>
		<lastmod>2011-05-23T07:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kodak-to-demonstrate-brand-protection-capabilities-for-pharma-packaging-230511/</loc>
		<lastmod>2011-05-23T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-depakote-sprinkle-capsules-230511/</loc>
		<lastmod>2011-05-23T08:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-bone-metastases-drug-receives-chmp-positive-opinion-230511/</loc>
		<lastmod>2011-05-23T08:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelion-seasonal-allergic-rhinitis-drug-phase-ii-trial-meets-primary-endpoint-230511/</loc>
		<lastmod>2011-05-23T08:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/paladin-labs-submits-oralair-nda-with-health-canada-240511/</loc>
		<lastmod>2011-05-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elekta-to-unveil-mosaiq-oncology-information-system-310511/</loc>
		<lastmod>2011-05-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ecaresoft-embeds-elearning-in-ehr-application-240511/</loc>
		<lastmod>2011-05-23T21:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli-lilly-forms-biocritica-with-care-capital-novaquest-240511/</loc>
		<lastmod>2011-05-23T23:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-amneal-pharma-to-manufacture-nitrofurantoin-oral-suspension-240511/</loc>
		<lastmod>2011-05-24T00:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/par-to-take-over-edict-pharma-240511/</loc>
		<lastmod>2011-05-24T02:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-pharma-to-buy-ab-sanitas-240511/</loc>
		<lastmod>2011-05-24T02:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nestle-health-science-to-acquire-prometheus-240511/</loc>
		<lastmod>2011-05-24T03:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-daiichi-sankyo-in-denosumab-co-promotion-pact-240511/</loc>
		<lastmod>2011-05-24T04:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sigma-aldrich-takes-over-vetec-quimica-fina-240511/</loc>
		<lastmod>2011-05-24T05:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advion-bioservices-establishes-bioanalytical-laboratory-in-indianapolis-240511/</loc>
		<lastmod>2011-05-24T06:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anavex-updates-on-alzheimers-drug-phase-i-trial-240511/</loc>
		<lastmod>2011-05-24T06:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-pharma-hepatitis-c-drug-recieves-fda-approval-240511/</loc>
		<lastmod>2011-05-24T06:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icon-central-laboratories-offers-new-cytometry-services-240511/</loc>
		<lastmod>2011-05-24T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ema-grants-marketing-approval-to-provepharm-methylthioninium-chloride-proveblue-240511/</loc>
		<lastmod>2011-05-24T07:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/skystar-q1-revenues-up-46-240511/</loc>
		<lastmod>2011-05-24T07:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/provectus-concludes-patient-recruitment-in-psoriasis-drug-phase-2c-trial-240511/</loc>
		<lastmod>2011-05-24T07:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/taro-pharma-otc-allergy-drug-gets-fda-approval-240511/</loc>
		<lastmod>2011-05-24T08:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/radius-3m-drug-delivery-systems-in-osteoporosis-treatment-collaboration-240511/</loc>
		<lastmod>2011-05-24T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abcam-acquires-mitosciences-240511/</loc>
		<lastmod>2011-05-24T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access-pharma-signs-distribution-agreement-with-emax-health-systems-250511/</loc>
		<lastmod>2011-05-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-pays-3m-milestone-under-amri-pact-250511/</loc>
		<lastmod>2011-05-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/insite-vision-fda-reach-agreement-over-double-study-250511/</loc>
		<lastmod>2011-05-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/achillion-pharma-starts-dosing-in-phase-1-hcv-drug-trial-250511/</loc>
		<lastmod>2011-05-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kempharm-releases-positive-results-from-pain-drug-phase-1-trial-250511/</loc>
		<lastmod>2011-05-25T00:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alcon-prevails-in-patanol-patent-case-against-apotex-250511/</loc>
		<lastmod>2011-05-25T01:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basilea-releases-bal30072-phase-i-trail-results-250511/</loc>
		<lastmod>2011-05-25T01:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-psychogenics-sign-cns-drug-discovery-pact-250511/</loc>
		<lastmod>2011-05-25T02:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sagent-pharma-to-launch-generic-zosyn-injection-250511/</loc>
		<lastmod>2011-05-25T03:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proteostasis-signs-drug-discovery-agreement-with-elan-250411/</loc>
		<lastmod>2011-05-25T03:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-presents-gouty-arthritis-drug-phase-iii-trials-results-250511/</loc>
		<lastmod>2011-05-25T04:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb-to-conduct-head-to-head-cimzia-humira-trial-250511/</loc>
		<lastmod>2011-05-25T04:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark-resolves-lawsuit-over-generic-locoid-lipocream-250511/</loc>
		<lastmod>2011-05-25T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centella-therapeutics-signs-license-agreement-with-auckland-uniservices-250511/</loc>
		<lastmod>2011-05-25T05:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/isconova-starts-vaccination-in-seasonal-influenza-vaccine-phase-i-trial-250511/</loc>
		<lastmod>2011-05-25T05:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gallus-biopharma-collaborates-with-xcellerex-250511/</loc>
		<lastmod>2011-05-25T06:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vivus-ed-drug-phase-3-trial-meets-primary-endpoints-250511/</loc>
		<lastmod>2011-05-25T06:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pathway-receives-fda-acceptance-for-filing-cancer-drug-ind-250511/</loc>
		<lastmod>2011-05-25T06:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/globe-all-wellness-voluntarily-recalls-weight-loss-dietary-supplement-250511/</loc>
		<lastmod>2011-05-25T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/marken-names-new-ceo-300511/</loc>
		<lastmod>2011-05-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-roxicodone-260511/</loc>
		<lastmod>2011-05-25T23:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protea-mayoly-spindler-conclude-phase-iii-ms1819-trial-260511/</loc>
		<lastmod>2011-05-25T23:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac-biotech-releases-hfmd-vaccine-phase-i-trial-results-260511/</loc>
		<lastmod>2011-05-26T01:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recombinant-maveric-to-develop-genisis-260511/</loc>
		<lastmod>2011-05-26T01:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson-pharma-takes-over-generic-drug-developer-specifar-260511/</loc>
		<lastmod>2011-05-26T02:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-research-uk-inks-pact-with-centella-for-cancer-drug-260511/</loc>
		<lastmod>2011-05-26T02:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vaya-pharma-introduces-memory-impairment-drug-260511/</loc>
		<lastmod>2011-05-26T03:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/germany-approves-sativex-oromucosal-spray-almirall-gw-pharma-260511/</loc>
		<lastmod>2011-05-26T03:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genmed-paracetamol-tablets-package-size-variation-receives-french-approval-260511/</loc>
		<lastmod>2011-05-26T03:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-district-court-rules-against-eli-lilly-in-amylin-case-260511/</loc>
		<lastmod>2011-05-26T04:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmanet-canada-hmr-sign-agreement-to-investigate-renel-drugs-260511/</loc>
		<lastmod>2011-05-26T04:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dynavax-concludes-heplisav-phase-3-trial-260511/</loc>
		<lastmod>2011-05-26T05:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mymetics-releases-hiv-vaccine-mym-v101-phase-i-trial-results-260511/</loc>
		<lastmod>2011-05-26T05:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb-reports-cimzia-realistic-trial-positive-results-260511/</loc>
		<lastmod>2011-05-26T05:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocis-pharma-oy-oy-lx-therapies-join-to-form-laurantis-pharma-oy-260511/</loc>
		<lastmod>2011-05-26T05:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cpc-in-pact-with-aastrom-for-ixmyelocel-t-phase-3-revive-clinical-studies-260511/</loc>
		<lastmod>2011-05-26T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/invida-sets-to-introduce-atopiclair-260511/</loc>
		<lastmod>2011-05-26T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmasset-starts-phase-2a-hcv-combination-drug-trial-260511/</loc>
		<lastmod>2011-05-26T07:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/personalized-goal-setting-helps-in-ra-improvement-ucb-study-270511/</loc>
		<lastmod>2011-05-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/insite-vision-merck-pfizer-sue-sandoz-on-generic-azasite-270511/</loc>
		<lastmod>2011-05-26T23:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-chooses-parexel-to-enhance-clinical-development-270511/</loc>
		<lastmod>2011-05-27T00:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/map-pharma-files-nda-for-migraine-drug-270511/</loc>
		<lastmod>2011-05-27T02:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ibio-produces-hookworm-derived-molecule-270511/</loc>
		<lastmod>2011-05-27T03:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-intends-to-rebrand-matrix-270511/</loc>
		<lastmod>2011-05-27T04:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reneuron-concludes-dosing-in-phase-i-pisces-trial-270511/</loc>
		<lastmod>2011-05-27T05:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adaptimmune-initiates-multiple-myeloma-drug-phase-iii-clinical-trial-270511/</loc>
		<lastmod>2011-05-27T07:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmascience-takes-over-aegera-270511/</loc>
		<lastmod>2011-05-27T07:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuron-biotech-to-develop-advanced-multiple-sclerosis-drug-270511/</loc>
		<lastmod>2011-05-27T07:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ema-validates-savient-krystexxa-maa-270511/</loc>
		<lastmod>2011-05-27T08:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sprix-nasal-spray-with-aptar-pharma-nasal-spray-pump-available-in-us-090611/</loc>
		<lastmod>2011-05-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thallion-pharma-lfb-recruit-first-patient-in-phase-ii-shigatec-trial-300511/</loc>
		<lastmod>2011-05-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-to-sell-paras-personal-care-business-300511/</loc>
		<lastmod>2011-05-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pg-sues-vi-jon-on-scope-outlast-mouthwash-300511/</loc>
		<lastmod>2011-05-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/optimer-pharma-antibacterial-drug-gets-fda-approval-300511/</loc>
		<lastmod>2011-05-29T23:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pbl-to-provide-manufacturing-process-for-biopharmaceutical-product-300511/</loc>
		<lastmod>2011-05-30T01:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e3-cbord-ink-pact-300511/</loc>
		<lastmod>2011-05-30T02:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cerecor-takes-over-cough-drug-from-fells-labs-300511/</loc>
		<lastmod>2011-05-30T02:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-aventis-dndi-collaborate-to-develop-drugs-for-ntds-300511/</loc>
		<lastmod>2011-05-30T03:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oceana-solesta-gel-gets-fda-nod-300511/</loc>
		<lastmod>2011-05-30T03:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nicox-releases-pah-drug-preclinical-study-results-300511/</loc>
		<lastmod>2011-05-30T05:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sun-pharma-q4-net-sales-rise-35-300511/</loc>
		<lastmod>2011-05-30T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/torrent-pharma-q4-net-sales-up-300511/</loc>
		<lastmod>2011-05-30T07:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/connell-brothers-to-distribute-industrial-chemicals-in-vietnam-300511/</loc>
		<lastmod>2011-05-30T07:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pci-biotech-receives-grant-from-research-council-of-norway-300511/</loc>
		<lastmod>2011-05-30T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d-pharm-in-licensing-pact-with-jiangsu-nhwa-310511/</loc>
		<lastmod>2011-05-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amri-obesity-drug-phase-i-trial-meets-primary-secondary-endpoints-310511/</loc>
		<lastmod>2011-05-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinion-on-cyt387-310511/</loc>
		<lastmod>2011-05-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-grants-human-liver-stem-cell-patent-to-multicell-technologies-310511/</loc>
		<lastmod>2011-05-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ventrus-biosciences-gets-noa-for-ven-307-patent-from-uspto-010611/</loc>
		<lastmod>2011-05-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tecan-enters-oem-deal-with-diagnostics-provider-310511/</loc>
		<lastmod>2011-05-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ic-tag-solutions-launches-rfid-tags-for-healthcare-industry-310511/</loc>
		<lastmod>2011-05-30T23:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym-biosciences-closes-nimotuzumab-trials-in-north-america-310511/</loc>
		<lastmod>2011-05-31T00:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-getgoal-lyxumia-phase-iii-study-meets-primary-endpoint-310511/</loc>
		<lastmod>2011-05-31T01:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-earns-milestone-payment-from-boehringer-ingelheim-310511/</loc>
		<lastmod>2011-05-31T02:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioalliance-pharma-names-new-ceo-310511/</loc>
		<lastmod>2011-05-31T03:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-heptares-sign-research-pact-310511/</loc>
		<lastmod>2011-05-31T04:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lochlomond-acquires-majority-share-in-ubichem-research-310511/</loc>
		<lastmod>2011-05-31T04:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarin-chooses-new-api-suppliers-encapsulators-for-amr101-310511/</loc>
		<lastmod>2011-05-31T05:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affymax-takeda-pharma-file-peginesatide-nda-310511/</loc>
		<lastmod>2011-05-31T07:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/triclinic-labs-enhances-chemical-development-capabilities-310511/</loc>
		<lastmod>2011-05-31T07:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/labcorp-plans-acquisition-of-clearstone-central-labs-010611/</loc>
		<lastmod>2011-05-31T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-pharma-pfizer-resolve-suit-on-generic-neurontin-010611/</loc>
		<lastmod>2011-05-31T23:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-army-grants-45m-to-ppd-010611/</loc>
		<lastmod>2011-05-31T23:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/idbs-widens-chemaxon-pact-010611/</loc>
		<lastmod>2011-05-31T23:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acelrx-pharma-receives-56m-grant-to-develop-pain-drug-010611/</loc>
		<lastmod>2011-06-01T01:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-allows-actavis-to-market-generic-aricept-in-us-010611/</loc>
		<lastmod>2011-06-01T02:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-nod-to-app-pharma-piperacillin-tazobactam-for-injection-010611/</loc>
		<lastmod>2011-06-01T02:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biosante-pharma-concludes-patient-recruitment-in-libigel-phase-iii-trial-010611/</loc>
		<lastmod>2011-06-01T03:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-gives-orphan-drug-status-to-develop-csl-behring-rviia-fp-010611/</loc>
		<lastmod>2011-06-01T04:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aurobindo-pharma-cns-drug-gets-fda-tentative-approval-010611/</loc>
		<lastmod>2011-06-01T05:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ajinomoto-to-unveil-glysom-010611/</loc>
		<lastmod>2011-06-01T06:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-to-qlt-synthetic-retinoid-program-010611/</loc>
		<lastmod>2011-06-01T06:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bausch-lomb-to-introduce-eye-care-products-in-india-010611/</loc>
		<lastmod>2011-06-01T07:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dyax-expands-hae-drug-pact-with-defiante-010611/</loc>
		<lastmod>2011-06-01T07:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antisense-pharma-portable-application-system-receives-patents-010611/</loc>
		<lastmod>2011-06-01T07:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health-enhancement-products-executes-rd-contract-with-battelle-010611/</loc>
		<lastmod>2011-06-01T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-pharma-soliris-sbla-gets-priority-review-status-from-fda-010611/</loc>
		<lastmod>2011-06-01T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/datatrak-widens-pact-with-ntt-data-020611/</loc>
		<lastmod>2011-06-01T18:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affymetrix-names-new-president-ceo-020611/</loc>
		<lastmod>2011-06-01T22:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sfda-licenses-tianyin-to-produce-anti-diabetic-drug-020611/</loc>
		<lastmod>2011-06-01T22:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-rcc-drug-receives-ema-acceptance-for-review-060211/</loc>
		<lastmod>2011-06-01T22:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-marketing-approval-for-teva-generic-alzheimers-drug-020611/</loc>
		<lastmod>2011-06-01T22:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spanish-regulators-give-manufacturing-license-to-midatech-biogune-020611/</loc>
		<lastmod>2011-06-02T01:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/agios-pharma-deploys-tripos-d360-software-020611/</loc>
		<lastmod>2011-06-02T01:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nextrials-to-unveil-clinical-trial-management-platform-prism-020611/</loc>
		<lastmod>2011-06-02T01:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inc-research-acquires-trident-clinical-research-020611/</loc>
		<lastmod>2011-06-02T02:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-croma-pharma-bausch-lomb-yellox-020611/</loc>
		<lastmod>2011-06-02T02:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-releases-lenvatinib-phase-ii-trial-preliminary-results-020611/</loc>
		<lastmod>2011-06-02T03:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/profectus-starts-hiv-vaccine-phase-i-trial-020611/</loc>
		<lastmod>2011-06-02T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fero-concludes-type-2-diabetes-drug-trial-in-middle-east-020611/</loc>
		<lastmod>2011-06-02T04:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myriad-genetics-acquires-rbm-020611/</loc>
		<lastmod>2011-06-02T04:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tioga-pharma-d-ibs-drug-gets-fda-fast-track-status-020611/</loc>
		<lastmod>2011-06-02T05:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotage-signs-research-pact-with-peptlab-020611/</loc>
		<lastmod>2011-06-02T05:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-patent-for-anadys-pharma-covering-setrobuvir-020611/</loc>
		<lastmod>2011-06-02T06:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/globeimmune-reports-cancer-vaccines-positive-results-020611/</loc>
		<lastmod>2011-06-02T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunovaccine-reports-cancer-vaccine-phase-i-trial-positive-results-020611/</loc>
		<lastmod>2011-06-02T07:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmanet-partners-with-cancer-immunotherapy-trials-network-020611/</loc>
		<lastmod>2011-06-02T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/therabiogen-launches-theramax-migraine-relief-020611/</loc>
		<lastmod>2011-06-02T08:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schiff-takes-over-ganeden-probiotic-technology-brands-for-40m-070611/</loc>
		<lastmod>2011-06-02T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovigilant-biologic-detection-systems-to-protect-pharma-manufacturing-areas-030611/</loc>
		<lastmod>2011-06-02T19:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-roche-in-yervoy-vemurafenib-clinical-collaboration-agreement-030611/</loc>
		<lastmod>2011-06-02T23:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-concludes-patient-enrollment-in-multiple-sclerosis-drug-phase-iii-trial-030611/</loc>
		<lastmod>2011-06-02T23:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clovis-oncology-to-develop-pfizer-cancer-drug-030611/</loc>
		<lastmod>2011-06-03T00:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/discoverx-expands-kinomescan-kinase-assay-panel-030611/</loc>
		<lastmod>2011-06-03T00:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tekmira-secures-licenses-from-alnylam-under-interferx-program-030611/</loc>
		<lastmod>2011-06-03T00:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-dndi-partner-to-develop-new-drugs-for-neglected-tropical-diseases-030611/</loc>
		<lastmod>2011-06-03T01:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-theravance-release-two-copd-drug-phase-iii-trial-results-030611/</loc>
		<lastmod>2011-06-03T01:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c3i-to-provide-technical-support-for-xbiotech-monoclonal-antibody-clinical-trial-030611/</loc>
		<lastmod>2011-06-03T02:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/global-health-ventures-selects-confab-for-x-excite-production-030611/</loc>
		<lastmod>2011-06-03T03:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-zhejiang-hisun-pharma-partner-to-offer-medicines-in-china-030611/</loc>
		<lastmod>2011-06-03T05:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-pharma-venlafaxine-hcl-extended-release-capsules-win-fda-approval-030611/</loc>
		<lastmod>2011-06-03T05:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/patrys-selects-laureate-to-manufacture-anti-cancer-drug-030611/</loc>
		<lastmod>2011-06-03T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunocellular-therapeutics-receives-access-to-biowa-potelligent-technology-030611/</loc>
		<lastmod>2011-06-03T07:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seaside-therapeutics-begins-fragile-x-syndrome-drug-clinical-trial-030611/</loc>
		<lastmod>2011-06-03T07:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ariad-pharma-reports-additional-clinical-findings-of-anti-leukemia-drug-070611/</loc>
		<lastmod>2011-06-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-macular-edema-drug-receives-ec-approval/</loc>
		<lastmod>2011-06-06T07:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glivec-improves-overall-survival-in-patients-with-gist-novartis-060611/</loc>
		<lastmod>2011-06-06T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/semuloparin-shows-64-risk-reduction-in-cancer-patients-sanofi-study-060611/</loc>
		<lastmod>2011-06-06T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/asmacure-ltee-names-new-ceo-060611/</loc>
		<lastmod>2011-06-06T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/easton-pharma-to-launch-fsad-drug-in-mexico-060611/</loc>
		<lastmod>2011-06-06T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-releases-avastin-oceans-study-results-060611/</loc>
		<lastmod>2011-06-06T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tekmira-pharma-modifies-lawsuit-against-alnylam-060611/</loc>
		<lastmod>2011-06-06T08:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen-to-terminate-irosustat-development-in-monotherapy-060611/</loc>
		<lastmod>2011-06-06T08:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lifecycle-pharma-gets-grant-to-develop-oral-chemotherapeutic-agent-060611/</loc>
		<lastmod>2011-06-06T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferrer-submits-tesamorelin-maa-060611/</loc>
		<lastmod>2011-06-06T08:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alampharm-to-distribute-nutra-pharma-otc-pain-reliever-060611/</loc>
		<lastmod>2011-06-06T08:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-warns-against-impax-hayward-manufacturing-facility-060611/</loc>
		<lastmod>2011-06-06T08:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/food-lion-to-sell-therabiogen-theramax-products-060611/</loc>
		<lastmod>2011-06-06T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/trion-pharma-reports-catumaxomab-trials-results-060611/</loc>
		<lastmod>2011-06-06T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/versartis-reports-human-growth-hormone-drug-positive-preclinical-safety-data-060611/</loc>
		<lastmod>2011-06-06T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-active-biotech-in-medicinal-chemistry-collaboration-060611/</loc>
		<lastmod>2011-06-06T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/benolea-from-frutarom-lowers-blood-pressure-level-study-060611/</loc>
		<lastmod>2011-06-06T08:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunovion-pharma-ciclesonide-hfa-gets-fda-acceptance-060611/</loc>
		<lastmod>2011-06-06T08:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivation-astellas-report-prostate-cancer-drug-ongoing-study-results-060611/</loc>
		<lastmod>2011-06-06T08:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elite-pharma-mikah-pharma-sign-manufacturing-supply-pact-060611/</loc>
		<lastmod>2011-06-06T08:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-mobius-mitosol-070611/</loc>
		<lastmod>2011-06-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antisense-pharma-releases-trabedersen-phase-iii-trial-results-080611/</loc>
		<lastmod>2011-06-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cook-medical-biopsy-needle-aids-in-gi-cancers-detection-study-070611/</loc>
		<lastmod>2011-06-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmapros-dataflow-manager-to-support-biotechnology-firm-070611/</loc>
		<lastmod>2011-06-06T21:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-phase-iii-alsympca-trial-meets-primary-endpoint-070611/</loc>
		<lastmod>2011-06-06T23:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-three-generic-drugs-in-us-070611/</loc>
		<lastmod>2011-06-07T01:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cellectis-vitamfero-in-pact-to-develop-vaccines-for-parasitic-infection-070611/</loc>
		<lastmod>2011-06-07T02:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/infomedics-establishes-new-office-in-paris-070611/</loc>
		<lastmod>2011-06-07T03:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/app-pharma-to-market-breast-cancer-drug-in-us-070611/</loc>
		<lastmod>2011-06-07T03:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-ariad-pharma-release-sarcoma-drug-trial-results-070611/</loc>
		<lastmod>2011-06-07T04:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-idec-avonex-pen-gets-ec-approval-070611/</loc>
		<lastmod>2011-06-07T05:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharming-group-megapharm-sign-pact-to-commercialize-hae-drug-in-israel-070611/</loc>
		<lastmod>2011-06-07T05:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxygen-gets-approval-to-conduct-stop-tbi-phase-iib-trial-in-india-070611/</loc>
		<lastmod>2011-06-07T05:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/durata-signs-manufacturing-agreement-for-dalbavancin-070611/</loc>
		<lastmod>2011-06-07T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prolor-biotech-reports-anti-obesity-drug-positive-preclinical-trial-results-070611/</loc>
		<lastmod>2011-06-07T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-allows-actavis-to-market-generic-insomnia-drug-070611/</loc>
		<lastmod>2011-06-07T07:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new-research-to-offer-design-to-develop-diabetes-cardiovascular-drugs-070611/</loc>
		<lastmod>2011-06-07T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-healthcare-submits-vegf-trap-eye-maa-in-europe-070611/</loc>
		<lastmod>2011-06-07T07:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza-to-expand-singapore-manufacturing-plant-080611/</loc>
		<lastmod>2011-06-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/matrix-generic-alzheimers-drug-gets-fda-approval-080611/</loc>
		<lastmod>2011-06-07T23:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/callidus-software-leverages-panopticon-visual-analysis-platform-080611/</loc>
		<lastmod>2011-06-07T23:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-watson-generic-contraceptive-pill-080611/</loc>
		<lastmod>2011-06-08T00:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-introduces-ad-drug-in-japan-080611/</loc>
		<lastmod>2011-06-08T01:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/conacyt-awards-research-grant-to-opko-080611/</loc>
		<lastmod>2011-06-08T02:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuralstem-in-agency-licensing-pact-with-spi-080611/</loc>
		<lastmod>2011-06-08T03:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-odd-to-edison-pharma-epi-743-080611/</loc>
		<lastmod>2011-06-08T03:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-conducts-overactive-bladder-drug-virtual-clinical-trial-080611/</loc>
		<lastmod>2011-06-08T04:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/denmark-approves-sativex-as-treatment-of-spasticity-due-to-ms-080611/</loc>
		<lastmod>2011-06-08T04:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affectis-pharma-signs-licensing-deal-with-merck-sereno-080611/</loc>
		<lastmod>2011-06-08T05:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-topaz-pharma-head-lice-treatment-nda-080611/</loc>
		<lastmod>2011-06-08T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elder-pharma-to-introduce-three-dozen-new-products-080611/</loc>
		<lastmod>2011-06-08T06:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/analgesic-drug-interim-analysis-shows-long-acting-pk-safety-profile-nektar-080611/</loc>
		<lastmod>2011-06-08T06:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/microdose-completes-atropine-dry-powder-phase-i-inhalation-trial-080611/</loc>
		<lastmod>2011-06-08T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-reflect-scientific-thermal-insulation-080611/</loc>
		<lastmod>2011-06-08T07:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/moberg-derma-signs-distribution-agreement-with-ozhealth-pharma-080611/</loc>
		<lastmod>2011-06-08T07:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-generic-xanax-xr-manufacturing-approval-to-aurobindo-pharma-080611/</loc>
		<lastmod>2011-06-08T07:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bio-nucleonics-resumes-cancer-drug-production-080611/</loc>
		<lastmod>2011-06-08T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/telik-commences-phase-telintra-2-trial-080611/</loc>
		<lastmod>2011-06-08T08:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/brazilian-regulatory-agency-approves-celerion-facilities-090611/</loc>
		<lastmod>2011-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunocellular-widens-gbm-vaccine-phase-ii-trial-090611/</loc>
		<lastmod>2011-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/marina-biotech-concludes-dosing-in-start-fap-trial-090611/</loc>
		<lastmod>2011-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avila-to-use-niaid-preclinical-services-program-to-evaluate-protease-inhibitor-090611/</loc>
		<lastmod>2011-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amerigen-pharma-signs-agreement-with-austarpharma-090611/</loc>
		<lastmod>2011-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kliniken-der-stadt-koln-adopts-luminex-xtag-gastrointestinal-pathogen-panel-090611/</loc>
		<lastmod>2011-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lsk-global-joins-aspire-to-win-channel-partner-program-090611/</loc>
		<lastmod>2011-06-08T23:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/targetrx-skura-introduce-pre-call-planning-software-tool-090611/</loc>
		<lastmod>2011-06-08T23:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-intercell-suspend-phase-iiiii-s-aureus-vaccine-trial-090611/</loc>
		<lastmod>2011-06-09T00:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-menb-vaccine-trials-meet-primary-endpoints-090611/</loc>
		<lastmod>2011-06-09T01:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hovione-psi-partner-to-jointly-accelerate-drug-solubilization-projects-090611/</loc>
		<lastmod>2011-06-09T02:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos-commences-ra-drug-phase-ii-trial-090611/</loc>
		<lastmod>2011-06-09T03:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-serono-completes-patient-recruitment-in-cancer-drug-trial-090611/</loc>
		<lastmod>2011-06-09T03:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/somaxon-pharma-selects-paladin-to-commercialize-silenor-090611/</loc>
		<lastmod>2011-06-09T04:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-agensys-to-jointly-develop-second-adc-090611/</loc>
		<lastmod>2011-06-09T05:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/omnia-implements-spraying-drying-to-stabilize-biologics-drugs-090611/</loc>
		<lastmod>2011-06-09T05:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designations-to-morphotek-cancer-drugs-090611/</loc>
		<lastmod>2011-06-09T06:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergy-therapeutics-updates-on-grass-mata-mpl-maa-090611/</loc>
		<lastmod>2011-06-09T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adamis-ind-application-for-prostrate-cancer-drug-gets-fda-nod-090611/</loc>
		<lastmod>2011-06-09T07:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-to-change-cholesterol-lowering-drug-safety-label-090611/</loc>
		<lastmod>2011-06-09T07:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/isconova-licenses-matrix-m-to-crucell-for-use-in-hiv-malaria-vaccines-090611/</loc>
		<lastmod>2011-06-09T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-court-vacates-temporary-restraining-order-on-lilly-in-amylin-case-090611/</loc>
		<lastmod>2011-06-09T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avi-biopharma-updates-on-eteplirsen-phase-2-trial-090611/</loc>
		<lastmod>2011-06-09T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/validus-deploys-veeva-systems-new-ipad-crm-solution-100611/</loc>
		<lastmod>2011-06-09T23:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest-labs-sets-to-launch-daliresp-in-us-100611/</loc>
		<lastmod>2011-06-09T23:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott-releases-data-from-advanced-parkinsons-disease-phase-ii-trial-100611/</loc>
		<lastmod>2011-06-09T23:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-emergent-anthrax-vaccine-100611/</loc>
		<lastmod>2011-06-10T01:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jdrf-signs-research-pact-with-selecta-100611/</loc>
		<lastmod>2011-06-10T01:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-to-lpath-100611/</loc>
		<lastmod>2011-06-10T02:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novagali-enters-into-agreement-with-ardeo-for-nova23041-100611/</loc>
		<lastmod>2011-06-10T03:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pivotal-therapeutics-to-launch-vascazen-in-us-canada-100611/</loc>
		<lastmod>2011-06-10T05:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb-agrees-to-pay-34m-in-anti-epileptic-drug-case-100611/</loc>
		<lastmod>2011-06-10T06:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-orphan-drug-status-to-tengion-neo-urinary-conduit-100611/</loc>
		<lastmod>2011-06-10T06:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synthes-lilly-sign-joint-development-agreement-100611/</loc>
		<lastmod>2011-06-10T07:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-aurobindo-pharma-generic-altace-capsules-100611/</loc>
		<lastmod>2011-06-10T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/moberg-derma-skin-disease-drug-receives-ce-mark-100611/</loc>
		<lastmod>2011-06-10T07:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/technology-strategy-board-to-provide-6m-grant-for-rd-projects-100611/</loc>
		<lastmod>2011-06-10T07:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/circassia-releases-phase-ii-cat-allergy-vaccine-trial-results-130611/</loc>
		<lastmod>2011-06-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-hanwha-sign-pact-for-biosimilar-candidate-130611/</loc>
		<lastmod>2011-06-13T00:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biota-scientific-gets-29m-grant-from-nih-130611/</loc>
		<lastmod>2011-06-13T00:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ge-healthcare-rapidscan-pharma-launch-rapiscan-in-uk-130611/</loc>
		<lastmod>2011-06-13T00:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nts-plus-affitech-amend-rd-licensing-agreement-130611/</loc>
		<lastmod>2011-06-13T01:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/millennium-seattle-genetics-release-two-adcetris-phase-1-trials-results-130611/</loc>
		<lastmod>2011-06-13T01:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-gsk-partial-onset-seizures-drug-gets-fda-approval-130611/</loc>
		<lastmod>2011-06-13T02:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tibet-pharma-designates-ceo-130611/</loc>
		<lastmod>2011-06-13T02:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/breckenridge-pharma-rolls-out-letrozole-25mg-tablets-130611/</loc>
		<lastmod>2011-06-13T03:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/edison-pharma-releases-friedreichs-ataxia-drug-trial-results-130611/</loc>
		<lastmod>2011-06-13T04:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mystic-pharma-receives-new-patent-for-drug-packaging-technology-130611/</loc>
		<lastmod>2011-06-13T05:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-pharma-phase-3-strive-study-meets-primary-secondary-endpoints-130611/</loc>
		<lastmod>2011-06-13T05:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kareus-quintiles-in-drug-development-alliance-130611/</loc>
		<lastmod>2011-06-13T05:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avacta-signs-analytical-services-agreement-with-pall-130611/</loc>
		<lastmod>2011-06-13T07:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-redesigned-drug-container-labels-receive-fda-approval-130611/</loc>
		<lastmod>2011-06-13T07:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ziopharm-receives-fda-acceptance-to-initiate-oncology-drug-trial-130611/</loc>
		<lastmod>2011-06-13T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-alios-biopharma-collaborate-to-develop-nucleotide-drug-candidates-130611/</loc>
		<lastmod>2011-06-13T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adaptimmune-initiates-phase-iii-metastatic-melanoma-drug-trial-130611/</loc>
		<lastmod>2011-06-13T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rxt-110-signs-license-agreement-with-marcus-martin-130611/</loc>
		<lastmod>2011-06-13T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/via-pharma-starts-patient-dosing-in-via-3196-phase-i-trial-130611/</loc>
		<lastmod>2011-06-13T07:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/paladin-labs-introduces-abstral-in-canada-140611/</loc>
		<lastmod>2011-06-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tetragenetics-names-new-ceo-140611/</loc>
		<lastmod>2011-06-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qrxpharma-concludes-moxduo-ir-comparative-phase-3-trial-140611/</loc>
		<lastmod>2011-06-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/divine-skin-to-introduce-otc-pain-reliever-140611/</loc>
		<lastmod>2011-06-13T23:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/servier-expects-to-acquire-complete-rights-of-cx1632-140611/</loc>
		<lastmod>2011-06-13T23:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cel-sci-starts-head-neck-cancer-drug-phase-iii-trial-in-hungary-140611/</loc>
		<lastmod>2011-06-13T23:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innovocommerce-formsvision-in-irt-solutions-collaboration-140611/</loc>
		<lastmod>2011-06-14T00:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cypress-pharma-cough-cold-drugs-get-fda-approval-140611/</loc>
		<lastmod>2011-06-14T02:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inventiv-health-acquires-i3-140611/</loc>
		<lastmod>2011-06-14T02:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apr-labtec-regain-ondansetron-odf-marketing-rights-140611/</loc>
		<lastmod>2011-06-14T03:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b-braun-drug-delivery-system-with-cephalosporins-receives-fda-approval-140611/</loc>
		<lastmod>2011-06-14T04:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sfda-approves-suzhou-erye-sixth-production-line-140611/</loc>
		<lastmod>2011-06-14T04:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quotient-amersham-radiochemicals-rebrands-to-quotient-custom-radiolabelling-140611/</loc>
		<lastmod>2011-06-14T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orexo-concludes-cancer-pain-drug-trial-140611/</loc>
		<lastmod>2011-06-14T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/easton-pharma-names-interim-ceo-140611/</loc>
		<lastmod>2011-06-14T06:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hp-industries-triad-group-finalize-consent-decree-with-fda-140611/</loc>
		<lastmod>2011-06-14T06:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-to-take-over-remaining-stake-in-gsknb-140611/</loc>
		<lastmod>2011-06-14T07:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bedford-labs-initiates-voluntary-recall-of-indomethacin-for-injection-140611/</loc>
		<lastmod>2011-06-14T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synageva-biopharma-signs-merger-agreement-with-trimeris-140611/</loc>
		<lastmod>2011-06-14T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mhra-allows-azellon-to-start-meniscal-tears-phase-i-clinical-trial-in-uk-140611/</loc>
		<lastmod>2011-06-14T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gentium-selects-link-pharma-as-distributor-of-defibrotide-150611/</loc>
		<lastmod>2011-06-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china-botanic-q2-net-sales-up-150611/</loc>
		<lastmod>2011-06-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-pharma-starts-shipping-generic-nasacort-aq-150611/</loc>
		<lastmod>2011-06-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-mitsubishi-cardiac-troponin-test-150611/</loc>
		<lastmod>2011-06-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocon-in-talks-with-bristol-myers-sanofi-150611/</loc>
		<lastmod>2011-06-15T00:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arecor-gsk-sign-licensing-deal-150611/</loc>
		<lastmod>2011-06-15T01:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bsi-launches-entropy-software-150611/</loc>
		<lastmod>2011-06-15T01:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott-epi-drug-for-cystic-fibrosis-gets-fda-approval-150611/</loc>
		<lastmod>2011-06-15T01:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneca-improves-male-enhancement-product-formulation-150611/</loc>
		<lastmod>2011-06-15T02:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-tap-compound-ind-triggers-2m-milestone-to-immunogen-150611/</loc>
		<lastmod>2011-06-15T03:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/app-pharm-expands-grand-island-manufacturing-plant-150611/</loc>
		<lastmod>2011-06-15T03:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-receives-fda-warning-letter-over-mexican-chemical-plant-150611/</loc>
		<lastmod>2011-06-15T04:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adolor-to-regain-entereg-rights-from-gsk-150611/</loc>
		<lastmod>2011-06-15T05:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ssb-sudpack-partner-for-plastic-films-150611/</loc>
		<lastmod>2011-06-15T06:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson-seeks-generic-pataday-02-marketing-approval-150611/</loc>
		<lastmod>2011-06-15T06:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck-completes-alcohol-dependence-drug-phase-3-clinical-study-150611/</loc>
		<lastmod>2011-06-15T07:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immatics-starts-rcc-vaccine-imprint-phase-iii-trial-150611/</loc>
		<lastmod>2011-06-15T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ceapro-signs-material-transfer-agreement-with-nrc-of-canada-150611/</loc>
		<lastmod>2011-06-15T07:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anvisa-approves-protalix-carmiel-manufacturing-plant-150611/</loc>
		<lastmod>2011-06-15T07:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/smb-approves-neuralstem-to-advance-als-clinical-trial-150611/</loc>
		<lastmod>2011-06-15T08:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alkermes-starts-trd-drug-phase-12-trial-150611/</loc>
		<lastmod>2011-06-15T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurogesx-concludes-phase-2-phn-drug-trial-160611/</loc>
		<lastmod>2011-06-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tioga-pharma-receives-new-us-patent-160611/</loc>
		<lastmod>2011-06-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-pharma-to-start-hib-vaccine-phase-iii-trial-in-japan-160611/</loc>
		<lastmod>2011-06-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mednet-solutions-to-unveil-eclinical-technology-suite-160611/</loc>
		<lastmod>2011-06-15T21:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-in-licensing-pact-with-nycomed-160611/</loc>
		<lastmod>2011-06-16T00:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-signs-research-pact-with-audion-160611/</loc>
		<lastmod>2011-06-16T01:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-lilly-launch-diabetes-drug-tradjenta-in-us-160611/</loc>
		<lastmod>2011-06-16T01:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmstar-pharma-files-us-patents-for-otc-pain-reliever-160611/</loc>
		<lastmod>2011-06-16T02:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clintec-widens-presence-in-asia-pacific-region-160611/</loc>
		<lastmod>2011-06-16T02:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-kidney-transplant-drug-gets-fda-nod-160611/</loc>
		<lastmod>2011-06-16T04:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inviragen-to-commence-hfmd-vaccine-phase-1-trial-160611/</loc>
		<lastmod>2011-06-16T05:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cevec-catalent-pharma-partner-to-offer-joint-cell-line-development-service-160611/</loc>
		<lastmod>2011-06-16T05:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lupin-takes-over-goanna-global-rights-160611/</loc>
		<lastmod>2011-06-16T05:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icl-performance-products-to-buy-cosmocel-quimica-160611/</loc>
		<lastmod>2011-06-16T06:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proimmune-introduces-new-protein-peptide-microarray-platform-160611/</loc>
		<lastmod>2011-06-16T06:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-novartis-diphtheria-vaccine-sbla-for-review-160611/</loc>
		<lastmod>2011-06-16T06:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/west-pharma-opens-new-manufacturing-plant-in-china-160611/</loc>
		<lastmod>2011-06-16T06:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/moulder-center-licenses-tripos-cadd-informatics-software-for-drug-discovery-160611/</loc>
		<lastmod>2011-06-16T07:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biondvax-phase-iia-influenza-vaccine-trial-shows-positive-results-160611/</loc>
		<lastmod>2011-06-16T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zealand-pharma-boehringer-collaborate-to-develop-type-2-diabetes-obesity-drugs-160611/</loc>
		<lastmod>2011-06-16T07:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scynexis-licenses-heos-drug-discovery-software-platform-to-tb-alliance-170611/</loc>
		<lastmod>2011-06-16T21:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cebix-starts-phase-1b-ersatta-trial-170611/</loc>
		<lastmod>2011-06-16T22:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-starts-manufacturing-plant-construction-in-st-petersburg-170611/</loc>
		<lastmod>2011-06-17T00:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reata-pharma-abbott-commence-beacon-phase-3-trial-170611/</loc>
		<lastmod>2011-06-17T01:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approval-for-celgene-istodax-for-injection-170611/</loc>
		<lastmod>2011-06-17T01:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oroxcell-secures-glp-certification-170611/</loc>
		<lastmod>2011-06-17T03:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lamellar-cystic-fibrosis-drug-gets-odd-from-ec-170611/</loc>
		<lastmod>2011-06-17T05:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/swisher-hygiene-buys-prinova-170611/</loc>
		<lastmod>2011-06-17T05:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-issues-written-guidance-to-generex-on-oral-lyn-170611/</loc>
		<lastmod>2011-06-17T06:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novabay-pharma-terminates-alcon-licensing-deal-170611/</loc>
		<lastmod>2011-06-17T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-asks-pfizer-to-further-evaluate-chantix-170611/</loc>
		<lastmod>2011-06-17T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-watson-nabumetone-tablets-170611/</loc>
		<lastmod>2011-06-17T08:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/supergen-updates-on-astex-acquisition-220611/</loc>
		<lastmod>2011-06-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/porsolt-jsw-sign-pact-220611/</loc>
		<lastmod>2011-06-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer-to-introduce-solid-phase-extraction-solutions-200611/</loc>
		<lastmod>2011-06-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medidata-solutions-releases-standards-accelerator-200611/</loc>
		<lastmod>2011-06-19T21:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ortho-mcneil-janssen-pharma-calls-back-schizophrenia-drug-200611/</loc>
		<lastmod>2011-06-20T00:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-phase-ii-bcc-drug-trial-meets-primary-endpoint-200611/</loc>
		<lastmod>2011-06-20T01:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/enterologics-to-take-over-biobalance-from-nyhc-200611/</loc>
		<lastmod>2011-06-20T02:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zydus-cadila-us-subsidiary-buys-nesher-200611/</loc>
		<lastmod>2011-06-20T03:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/researchers-develop-new-drug-for-cystic-fibrosis-200611/</loc>
		<lastmod>2011-06-20T04:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/precision-dynamics-to-offer-labeling-solutions-to-novation-novaplus-200611/</loc>
		<lastmod>2011-06-20T05:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sipo-issues-new-patent-for-aoxing-pharma-psychotropic-drug-200611/</loc>
		<lastmod>2011-06-20T05:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/akzonobel-invests-140m-in-frankfurt-chlorine-plant-200611/</loc>
		<lastmod>2011-06-20T05:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sfda-asks-gsk-to-withdraw-augmentin-syrup-200611/</loc>
		<lastmod>2011-06-20T07:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viropharma-receives-ec-approval-for-cinryze-200611/</loc>
		<lastmod>2011-06-20T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-glenmark-oral-contraceptive-drug-200611/</loc>
		<lastmod>2011-06-20T07:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wipro-develops-cloud-based-portal-for-clinical-trials-220611/</loc>
		<lastmod>2011-06-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo-fisher-to-launch-chromatography-products-210611/</loc>
		<lastmod>2011-06-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transperfect-sentrx-collaborate-to-provide-pharmacovigilance-safety-solution-210611/</loc>
		<lastmod>2011-06-20T20:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/futura-medical-erection-enhancing-condom-gets-eu-recommendation-210611/</loc>
		<lastmod>2011-06-20T23:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-abbott-prostate-cancer-formulation-210611/</loc>
		<lastmod>2011-06-21T00:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/topica-releases-10-luliconazole-solution-phase-12a-trial-results-210611/</loc>
		<lastmod>2011-06-21T00:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alder-biopharma-to-receive-milestone-payment-from-bristol-myers-squibb-210611/</loc>
		<lastmod>2011-06-21T00:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pulmatrix-introduces-inhaled-dry-powder-drug-delivery-platform-isperse-210611/</loc>
		<lastmod>2011-06-21T01:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jubilant-endo-achieve-late-stage-discovery-milestone-210611/</loc>
		<lastmod>2011-06-21T02:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approval-for-pfizer-acura-pain-drug-210611/</loc>
		<lastmod>2011-06-21T02:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand-to-commercially-supply-captisol-to-merck-210611/</loc>
		<lastmod>2011-06-21T02:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evonik-ups-pharmaceutical-amino-acid-glycine-production-capacity-210611/</loc>
		<lastmod>2011-06-21T05:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quotient-clinical-medigene-in-rapidfact-program-agreement-210611/</loc>
		<lastmod>2011-06-21T05:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bac-partners-with-life-technologies-to-provide-new-hplc-affinity-columns-210611/</loc>
		<lastmod>2011-06-21T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gentium-medison-pharma-in-defibrotide-license-distribution-agreement-210611/</loc>
		<lastmod>2011-06-21T07:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-final-approval-to-hi-tech-levofloxacin-oral-solution-anda-210611/</loc>
		<lastmod>2011-06-21T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amylin-lilly-alkermes-bydureon-receives-marketing-authorization-in-europe-220611/</loc>
		<lastmod>2011-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ritter-pharma-recruits-first-patient-in-lactose-intolerance-drug-trial-220611/</loc>
		<lastmod>2011-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza-launches-light-path-240611/</loc>
		<lastmod>2011-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-chooses-exco-intouch-ediary-technologies-220611/</loc>
		<lastmod>2011-06-21T22:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/depomed-sues-sun-pharma-for-generic-glumetza-220611/</loc>
		<lastmod>2011-06-22T00:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/csl-receives-fda-warning-letter-for-parkville-manufacturing-plant-220611/</loc>
		<lastmod>2011-06-22T00:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott-biotest-sign-ra-psoriasis-drug-development-pact-220611/</loc>
		<lastmod>2011-06-22T02:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/threshold-pharma-concludes-recruitment-in-pancreatic-cancer-drug-phase-2-trial-220611/</loc>
		<lastmod>2011-06-22T02:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-rolls-out-generic-levofloxacin-tablets-in-us-220611/</loc>
		<lastmod>2011-06-22T03:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atrium-initiates-nutrition-research-program-for-metabolic-syndrome-220611/</loc>
		<lastmod>2011-06-22T05:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prolor-biotech-receives-ema-acceptance-to-review-hgh-ctp-pip-220611/</loc>
		<lastmod>2011-06-22T05:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seaside-starts-phase-2b-asd-drug-trial-220611/</loc>
		<lastmod>2011-06-22T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chinese-pharma-firm-chooses-pharmatech-for-facility-design-compliance-220611/</loc>
		<lastmod>2011-06-22T06:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmasset-receives-new-us-patent-for-hcv-drug-220611/</loc>
		<lastmod>2011-06-22T07:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apeiron-biologics-ccri-siopen-partner-to-develop-neuroblastoma-drug-220611/</loc>
		<lastmod>2011-06-22T07:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunocellular-cancer-vaccine-technology-receives-us-patent-220611/</loc>
		<lastmod>2011-06-22T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pure-bioscience-hard-surface-disinfectant-receives-canada-approval-230611/</loc>
		<lastmod>2011-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/achillion-commences-patient-dosing-in-ach-1625-phase-2a-trial-230611/</loc>
		<lastmod>2011-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-commences-two-phase-2b-gsk-052-trials-230611/</loc>
		<lastmod>2011-06-23T00:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accenture-introduces-national-ehr-system-in-singapore-230611/</loc>
		<lastmod>2011-06-23T01:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson-to-expand-salt-lake-city-rd-manufacturing-facility-230611/</loc>
		<lastmod>2011-06-23T01:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cmc-biologics-updates-on-pf2-manufacturing-plant-expansion-230611/</loc>
		<lastmod>2011-06-23T02:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-inaugurates-new-vaccine-rd-facility-in-toronto/</loc>
		<lastmod>2011-06-23T02:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivir-selects-daewoong-to-distribute-xerclear-in-china-hong-kong-230611/</loc>
		<lastmod>2011-06-23T03:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lupin-antibacterial-tablet-receives-fda-approval-230611/</loc>
		<lastmod>2011-06-23T04:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lupin-natco-pharma-to-jointly-commercialize-generic-breast-cancer-drug-230611/</loc>
		<lastmod>2011-06-23T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/naurex-commences-antidepressant-drug-phase-ii-trial-230811/</loc>
		<lastmod>2011-06-23T05:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn-pharma-concludes-patient-recruitment-in-phase-iib-mdd-drug-trial-230611/</loc>
		<lastmod>2011-06-23T05:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jubilant-astrazeneca-deliver-early-milestone-in-pain-therapeutic-area-230611/</loc>
		<lastmod>2011-06-23T05:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih-funds-p2d-bioscience-to-develop-dopamine-transport-inhibitor-230611/</loc>
		<lastmod>2011-06-23T05:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-prostrakan-rectiv-230611/</loc>
		<lastmod>2011-06-23T06:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bmbf-awards-research-grant-to-scil-technology-230611/</loc>
		<lastmod>2011-06-23T06:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innavirvax-reports-positive-hiv-drug-preclinical-trial-results-230611/</loc>
		<lastmod>2011-06-23T07:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tobira-starts-cenicriviroc-phase-iib-trial-230611/</loc>
		<lastmod>2011-06-23T08:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fera-pharma-introduces-garamycin-ophthalmic-solution-240611/</loc>
		<lastmod>2011-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viropharma-anti-epileptic-drug-puma-receives-chmp-positive-opnion-240611/</loc>
		<lastmod>2011-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/canam-epitherapeutics-sign-medicinal-chemistry-research-services-pact-240611/</loc>
		<lastmod>2011-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/randox-launches-new-automated-laboratory-assay-for-h-fabp-240611/</loc>
		<lastmod>2011-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pd-rx-pharma-acquires-washington-emr-from-wilson-medical-240611/</loc>
		<lastmod>2011-06-23T23:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-epilepsy-drug-receives-ema-acceptance-for-review-240611/</loc>
		<lastmod>2011-06-24T00:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fero-industries-selects-pnp-pharma-as-sucanon-global-manufacturer-240611/</loc>
		<lastmod>2011-06-24T00:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vhgi-names-ceo-for-mos-240611/</loc>
		<lastmod>2011-06-24T01:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-to-roll-out-generic-crohns-disease-drug-in-us-240611/</loc>
		<lastmod>2011-06-24T02:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orient-europharma-to-start-neck-cancer-drug-phase-iii-trial-in-taiwan-240611/</loc>
		<lastmod>2011-06-24T02:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-roche-collaborate-to-develop-oncology-biomarkers-240611/</loc>
		<lastmod>2011-06-24T03:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meda-submits-zyclara-maa-with-ema-240611/</loc>
		<lastmod>2011-06-24T03:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aragen-bioscience-to-offer-in-vivo-services-240611/</loc>
		<lastmod>2011-06-24T03:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-synageva-biopharma-lal-drug-240611/</loc>
		<lastmod>2011-06-24T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-to-retain-presence-on-sandwich-site-240611/</loc>
		<lastmod>2011-06-24T05:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amsterdam-molecular-glybera-maa-receives-chmp-negative-opinion-240611/</loc>
		<lastmod>2011-06-24T05:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarin-to-acquire-pfizer-ireland-manufacturing-plant-240611/</loc>
		<lastmod>2011-06-24T05:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/invasc-starts-phase-iia-ckd-drug-trial-240611/</loc>
		<lastmod>2011-06-24T06:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-establihes-rd-institute-in-france-240611/</loc>
		<lastmod>2011-06-24T06:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent-anthrax-vaccine-receives-singapore-hsa-approval-240611/</loc>
		<lastmod>2011-06-24T07:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-issues-crl-for-pfizer-remoxy-nda-240611/</loc>
		<lastmod>2011-06-24T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biota-releases-shield-phase-iii-prophylaxis-study-preliminary-results-270611/</loc>
		<lastmod>2011-06-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adocia-starts-phase-iia-human-insulin-trial-280611/</loc>
		<lastmod>2011-06-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/connexios-unveils-diabetes-drug-preclinical-data-280611/</loc>
		<lastmod>2011-06-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accudial-pharma-selects-broadmed-for-childrens-accudial-290611/</loc>
		<lastmod>2011-06-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-grants-positive-opinion-for-novartis-sega-drug-270611/</loc>
		<lastmod>2011-06-26T23:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-pays-eur5m-to-ablynx-270611/</loc>
		<lastmod>2011-06-27T01:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-releases-all-to-target-study-results-270611/</loc>
		<lastmod>2011-06-27T02:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-receives-milestone-payment-from-ono-270611/</loc>
		<lastmod>2011-06-27T03:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nj-hitec-selects-intivia-as-ehr-vendor-270611/</loc>
		<lastmod>2011-06-27T03:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-millennium-receive-fda-acceptance-for-adcetris-maa-270611/</loc>
		<lastmod>2011-06-27T03:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jhp-pharma-names-new-ceo-270611/</loc>
		<lastmod>2011-06-27T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/erytech-pharma-concludes-phase-i-trial-pancreatic-cancer-drug-trial-270611/</loc>
		<lastmod>2011-06-27T08:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-receives-ema-approval-for-replagal-purification-in-lexington-plant-270611/</loc>
		<lastmod>2011-06-27T08:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biothera-releases-b-glucans-study-results-280611/</loc>
		<lastmod>2011-06-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/experian-acquires-medical-present-value-for-185m-280611/</loc>
		<lastmod>2011-06-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/edgebio-opts-caliper-workstation-for-sequencing-workflow-050711/</loc>
		<lastmod>2011-06-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/columbia-labs-watson-receive-fda-acceptance-for-prochieve-nda-280611/</loc>
		<lastmod>2011-06-28T00:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-pharma-to-start-neck-cancer-drug-phase-iii-trial-in-israel-280611/</loc>
		<lastmod>2011-06-28T01:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/althea-obtains-fda-license-to-manufacture-package-product-for-us-market-280611/</loc>
		<lastmod>2011-06-28T01:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/provence-technologies-collaborates-with-nexgenix-pharma-280611/</loc>
		<lastmod>2011-06-28T02:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dyadic-inks-pact-with-animal-feed-enzyme-products-provider-280611/</loc>
		<lastmod>2011-06-28T03:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/resprotect-regains-pancreatic-cancer-drug-north-american-rights-280611/</loc>
		<lastmod>2011-06-28T04:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-files-sbla-for-xgeva-280611/</loc>
		<lastmod>2011-06-28T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pinnacle-oncology-acquires-radioprotector-rights-from-university-of-chicago-280611/</loc>
		<lastmod>2011-06-28T05:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark-receives-25m-upfront-payment-from-sanofi-280611/</loc>
		<lastmod>2011-06-28T06:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lct-recruits-two-patients-in-phase-ii-diabecell-trial/</loc>
		<lastmod>2011-06-28T06:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-funds-redwood-to-develop-protein-modification-technology-280611/</loc>
		<lastmod>2011-06-28T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/to-bbb-to-begin-patient-recruitment-in-2b3-101-phase-iiia-trial-280611/</loc>
		<lastmod>2011-06-28T06:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ema-accepts-ferrer-anti-lipid-drug-maa-for-review-280611/</loc>
		<lastmod>2011-06-28T06:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nycomed-pays-10m-to-immunomedics-280611/</loc>
		<lastmod>2011-06-28T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-receives-5m-from-millennium-280611/</loc>
		<lastmod>2011-06-28T07:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolinerxyissum-in-license-agreement-to-develop-ibd-drug-280611/</loc>
		<lastmod>2011-06-28T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scifluor-life-sciences-names-new-ceo-280611/</loc>
		<lastmod>2011-06-28T08:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-in-pact-with-matrix-for-hiv-drugs-290611/</loc>
		<lastmod>2011-06-28T23:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicinesconsult-to-distribute-nutra-pharma-nyloxin-pain-relievers-in-jordan-290611/</loc>
		<lastmod>2011-06-29T00:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-pfizer-rcc-drug-application-for-review-290611/</loc>
		<lastmod>2011-06-29T00:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/california-fdb-inspects-sherpa-clinical-packaging-facility-290611/</loc>
		<lastmod>2011-06-29T00:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ups-expands-distribution-logistics-agreement-with-merck-290611/</loc>
		<lastmod>2011-06-29T00:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xerox-medco-launch-communication-delivery-platform-for-healthcare-information-290611/</loc>
		<lastmod>2011-06-29T01:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-sciences-tibotec-sign-drug-development-deal-290611/</loc>
		<lastmod>2011-06-29T03:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-yakuhin-files-maa-for-eylea-with-mhlw-in-japan-290611/</loc>
		<lastmod>2011-06-29T03:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-nuvo-research-lidocaine-spray-ind-290611/</loc>
		<lastmod>2011-06-29T04:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stepan-specialty-takes-over-lipid-nutrition-product-lines-290611/</loc>
		<lastmod>2011-06-29T05:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli-lilly-to-strengthen-biotechnology-capabilities-290611/</loc>
		<lastmod>2011-06-29T05:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivir-amends-terms-of-cold-sores-drug-pact-with-meda-290611/</loc>
		<lastmod>2011-06-29T05:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac-starts-hfmd-vaccine-phase-ii-trial-290611/</loc>
		<lastmod>2011-06-29T06:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/newron-merck-serono-conclude-patient-recruitment-in-phase-iii-motion-study-290611/</loc>
		<lastmod>2011-06-29T06:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atley-pharma-licenses-branded-products-to-hi-tech-290611/</loc>
		<lastmod>2011-06-29T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amri-in-pact-with-proteros-biostructures-290611/</loc>
		<lastmod>2011-06-29T07:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/progenics-files-relistor-snda-with-fda-290611/</loc>
		<lastmod>2011-06-29T07:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-rise-ride-dme-drug-trials-meet-primary-endpoints-290611/</loc>
		<lastmod>2011-06-29T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/starpharma-selects-docetaxel-for-cancer-drug-delivery-program-300611/</loc>
		<lastmod>2011-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basilea-pharma-commences-phase-i-anticancer-drug-trial-300611/</loc>
		<lastmod>2011-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allegro-enters-into-license-deal-for-molecular-testing-platform-300611/</loc>
		<lastmod>2011-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmstar-pharma-expands-aquaprin-product-line-300611/</loc>
		<lastmod>2011-06-29T23:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elite-pharma-thepharmanetwork-sign-manufacturing-deal-300611/</loc>
		<lastmod>2011-06-30T00:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-ptc-ink-research-licensing-pact-300611/</loc>
		<lastmod>2011-06-30T00:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-dendreon-los-angeles-provenge-manufacturing-facility-300611/</loc>
		<lastmod>2011-06-30T01:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schreiner-medipharm-introduces-film-based-solution-for-blinding-blister-packs-300611/</loc>
		<lastmod>2011-06-30T01:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-glow2-copd-drug-trial-meets-primary-endpoint-300611/</loc>
		<lastmod>2011-06-30T01:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drummond-certifies-accumedic-emr-system-300611/</loc>
		<lastmod>2011-06-30T02:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meda-to-sell-elidel-xerese-rights-to-valeant-300611/</loc>
		<lastmod>2011-06-30T02:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest-laboratories-almirall-file-copd-drug-nda-with-fda-300611/</loc>
		<lastmod>2011-06-30T03:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-rebrands-animal-division-300611/</loc>
		<lastmod>2011-06-30T04:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb-establishes-research-alliance-with-harvard-university-300611/</loc>
		<lastmod>2011-06-30T05:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-inks-research-agreement-with-weill-cornell-medical-college-300611/</loc>
		<lastmod>2011-06-30T05:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imre-develops-synthetic-cell-membranes-to-speed-up-drug-discovery-process-300611/</loc>
		<lastmod>2011-06-30T06:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cipher-gives-cip-tramadol-er-us-marketing-rights-to-vertical-pharma-300611/</loc>
		<lastmod>2011-06-30T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rxmd-signs-drug-development-agreement-with-glycoregimmune-300611/</loc>
		<lastmod>2011-06-30T07:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-chemrar-sign-mou-to-explore-drug-research-development-in-russia-300611/</loc>
		<lastmod>2011-06-30T08:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/agennix-starts-patient-dosing-in-sepsis-drug-phase-ii-oasis-trial-300611/</loc>
		<lastmod>2011-06-30T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sorbent-receives-additional-36m-in-series-b-financing-010711/</loc>
		<lastmod>2011-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/metamark-collaborates-with-definiens-for-cancers-assays-010711/</loc>
		<lastmod>2011-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-files-lawsuit-against-aurobindo-pharma-010711/</loc>
		<lastmod>2011-07-01T03:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-sagent-pharma-polymyxin-b-for-injection-usp-010711/</loc>
		<lastmod>2011-07-01T03:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-biopontis-alliance-in-translational-technology-development-agreement-010711/</loc>
		<lastmod>2011-07-01T03:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/royalty-pharma-acquires-diabetes-treatment-patents-from-astellas-subsidiary-010711/</loc>
		<lastmod>2011-07-01T03:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vandalia-research-gets-104m-us-department-of-defense-contract-010711/</loc>
		<lastmod>2011-07-01T03:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advance-pharma-gets-license-to-market-boston-therapeutics-sugardown-010711/</loc>
		<lastmod>2011-07-01T03:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas-pharma-oab-drug-gets-japanese-approval-010711/</loc>
		<lastmod>2011-07-01T03:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest-labs-rolls-out-mdd-drug-in-us-010711/</loc>
		<lastmod>2011-07-01T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health-canada-allows-acasti-pharma-to-initiate-capre-phase-ii-trial-010711/</loc>
		<lastmod>2011-07-01T04:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amerisourcebergen-names-new-president-ceo-010711/</loc>
		<lastmod>2011-07-01T05:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quotient-bioresearch-signs-agreement-with-cambridge-research-biochemicals-010711/</loc>
		<lastmod>2011-07-01T06:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bausch-lomb-partners-with-micro-labs-to-establish-pharma-business-in-india-010711/</loc>
		<lastmod>2011-07-01T07:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acura-receives-milestone-payment-from-pfizer-040711/</loc>
		<lastmod>2011-07-03T23:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/whitec-chooses-athenahealth-as-ehr-vendor-partner-040711/</loc>
		<lastmod>2011-07-03T23:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/miragen-licensed-study-finds-role-for-mir-133a-as-human-cnm-modulator-040711/</loc>
		<lastmod>2011-07-03T23:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-files-patent-infringement-lawsuits-against-sandoz-amneal-040711/</loc>
		<lastmod>2011-07-03T23:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approval-for-novartis-arcapta-neohaler-040711/</loc>
		<lastmod>2011-07-04T00:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/aaipharma-durham-analytical-lab-passes-fda-inspection-040711/</loc>
		<lastmod>2011-07-04T00:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-idec-finds-new-approach-to-treat-multiple-sclerosis-040711/</loc>
		<lastmod>2011-07-04T01:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acorda-medtronic-in-sci-tbi-treatment-licensing-deal-040711/</loc>
		<lastmod>2011-07-04T01:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amway-introduces-nutrilite-memory-builder-in-north-america-040711/</loc>
		<lastmod>2011-07-04T02:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/glenmark-settles-patent-case-with-daiichi-genzyme-040711/</loc>
		<lastmod>2011-07-04T05:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-daiichi-sankyo-to-co-promote-rotarix-in-japan-040711/</loc>
		<lastmod>2011-07-04T05:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sorrento-receives-sttr-grant-to-develop-mrsa-vaccines-040711/</loc>
		<lastmod>2011-07-04T07:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-pharma-new-oral-anticoagulant-receives-fda-approval-040711/</loc>
		<lastmod>2011-07-04T07:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recordati-agrees-to-acquire-frik-ilac-040711/</loc>
		<lastmod>2011-07-04T07:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytrx-soft-tissue-sarcomas-drug-gets-fda-odd-050711/</loc>
		<lastmod>2011-07-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ampio-pharma-treats-first-patient-in-phase-1b-aik-trial-050711/</loc>
		<lastmod>2011-07-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chantix-effective-to-quit-smoking-pfizer-050711/</loc>
		<lastmod>2011-07-04T23:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/swisher-takes-over-sanolite-050711/</loc>
		<lastmod>2011-07-05T00:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-app-pharma-myxedema-coma-treatment-050711/</loc>
		<lastmod>2011-07-05T01:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-breast-cancer-drug-trial-meets-primary-endpoint-050711/</loc>
		<lastmod>2011-07-05T01:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diamyd-medica-designates-ceo-050711/</loc>
		<lastmod>2011-07-05T01:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/octoplus-in-pact-with-danish-pharma-firm-050711/</loc>
		<lastmod>2011-07-05T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mhlw-approves-takeda-type-2-diabetes-drug-in-japan-050711/</loc>
		<lastmod>2011-07-05T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fortis-healthcare-names-new-ceo-050711/</loc>
		<lastmod>2011-07-05T05:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/marck-to-introduce-paracetamol-iv-in-plastic-package-in-india-050711/</loc>
		<lastmod>2011-07-05T06:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/agennix-releases-talactoferrin-phase-ii-trial-data-050711/</loc>
		<lastmod>2011-07-05T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolinerx-recruits-first-patient-in-phase-i-neuropathic-pain-drug-trial-050711/</loc>
		<lastmod>2011-07-05T08:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuvo-research-validate-pliaglis-maa-in-eu-050711/</loc>
		<lastmod>2011-07-05T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genetix-drug-discovery-division-to-join-forces-with-molecular-devices-060711/</loc>
		<lastmod>2011-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mingsight-relin-form-jv-to-develop-diabetic-eye-disease-drug-in-china-060711/</loc>
		<lastmod>2011-07-05T22:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jhp-pharma-introduces-larger-pack-sizes-for-three-injectable-products-060711/</loc>
		<lastmod>2011-07-05T22:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-submits-registration-application-for-tesamorelin-in-israel-060711/</loc>
		<lastmod>2011-07-05T23:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/carefusion-to-take-over-rowa-for-150m-060711/</loc>
		<lastmod>2011-07-06T00:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-ucb-to-pact-with-nasa-060711/</loc>
		<lastmod>2011-07-06T00:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-signs-research-pact-with-rib-x-pharma-060711/</loc>
		<lastmod>2011-07-06T01:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-app-pharma-nafcillin-for-injection-usp-060711/</loc>
		<lastmod>2011-07-06T02:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cadila-receives-fda-warning-letter-for-gmp-violations-060711/</loc>
		<lastmod>2011-07-06T02:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-to-return-type-ii-diabetes-drug-development-rights-to-chugai-060711/</loc>
		<lastmod>2011-07-06T03:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vantia-receives-4m-in-series-b-financing-060711/</loc>
		<lastmod>2011-07-06T04:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-releases-top-line-results-from-lyrica-study-060711/</loc>
		<lastmod>2011-07-06T05:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/almirall-introduces-ms-drug-sativex-in-germany-060711/</loc>
		<lastmod>2011-07-06T05:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ark-receives-finnish-grant-060711/</loc>
		<lastmod>2011-07-06T06:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-lupin-hypertension-drug-060711/</loc>
		<lastmod>2011-07-06T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmasset-signs-clinical-pact-with-tibotec-to-start-hcv-drug-phase-2-trial-060711/</loc>
		<lastmod>2011-07-06T06:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-raptor-pharma-cysteamine-portfolio-060711/</loc>
		<lastmod>2011-07-06T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innovacyn-introduces-eye-ear-formulations-060711/</loc>
		<lastmod>2011-07-06T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-fast-track-status-to-medivir-for-chc-drug-060711/</loc>
		<lastmod>2011-07-06T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cambrextillotts-pharma-ink-development-pact-070711/</loc>
		<lastmod>2011-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antisense-pharma-raises-eur8m-070711/</loc>
		<lastmod>2011-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drummond-certifies-simplicity-emr-070711/</loc>
		<lastmod>2011-07-06T22:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-innate-pharma-in-oncology-drug-license-agreement-070711/</loc>
		<lastmod>2011-07-06T23:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nccn-awards-grant-to-threshold-hypoxia-targeted-prodrug-clinical-trial-070711/</loc>
		<lastmod>2011-07-06T23:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gentium-files-nda-for-vod-drug/</loc>
		<lastmod>2011-07-07T00:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-allows-nycomed-to-market-cancer-drug-in-europe-070711/</loc>
		<lastmod>2011-07-07T01:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genedata-launches-biologics-data-management-platform-070711/</loc>
		<lastmod>2011-07-07T02:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wellstat-sells-uridine-triacetate-rights-to-btg-070711/</loc>
		<lastmod>2011-07-07T02:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/addf-awards-msdc-grant-to-conduct-alzheimers-drug-phase-2a-trial-070711/</loc>
		<lastmod>2011-07-07T02:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-lotrel-capsules-in-us-070711/</loc>
		<lastmod>2011-07-07T03:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-prohibits-dr-reddys-drugs-manufactured-at-mexican-plant-070711/</loc>
		<lastmod>2011-07-07T04:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-ucb-sign-cns-drug-discovery-deal-070711/</loc>
		<lastmod>2011-07-07T05:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-tentative-approval-for-lupin-generic-lyrica-070711/</loc>
		<lastmod>2011-07-07T06:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mabion-commences-cancer-drug-clinical-trial-070711/</loc>
		<lastmod>2011-07-07T07:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/institut-pasteur-signs-research-pact-with-stragen/</loc>
		<lastmod>2011-07-07T07:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zafgen-raises-33m-for-obecity-drug-clinical-trials-070711/</loc>
		<lastmod>2011-07-07T07:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anavex-starts-30mg-dose-step-in-alzheimers-drug-phase-1-trial-070711/</loc>
		<lastmod>2011-07-07T07:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-sues-roxane-watson-on-generic-adhd-drug-080711/</loc>
		<lastmod>2011-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-suspends-pallas-phase-iiib-af-drug-trial-080711/</loc>
		<lastmod>2011-07-08T00:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jhp-pharma-in-pact-to-produce-life-saving-drugs-080711/</loc>
		<lastmod>2011-07-08T01:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valuecentric-launches-valuetrak-mobile-080711/</loc>
		<lastmod>2011-07-08T02:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sagent-pharma-rolls-out-generic-levaquin-080711/</loc>
		<lastmod>2011-07-08T02:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kane-biotech-files-dispersinb-briefing-document-with-fda-080711/</loc>
		<lastmod>2011-07-08T02:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioexx-specialty-century-foods-to-jointly-develop-bioexx-proteins-080711/</loc>
		<lastmod>2011-07-08T03:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prometic-receives-additional-4m-purchase-order-from-pharma-firm-080711/</loc>
		<lastmod>2011-07-08T04:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/solvo-to-provide-drug-transporter-services-to-cyprotex-customers-080711/</loc>
		<lastmod>2011-07-08T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cprit-roche-partner-for-cancer-research-in-texas-080711/</loc>
		<lastmod>2011-07-08T06:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/palonosetron-prevents-nausea-in-lung-cancer-patients-study-080711/</loc>
		<lastmod>2011-07-08T07:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prostrakan-designates-new-ceo-080711/</loc>
		<lastmod>2011-07-08T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/safc-launches-cho-cell-lines-to-speed-up-bioproduction-080711/</loc>
		<lastmod>2011-07-08T07:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amt-files-request-with-ema-to-re-examine-glybera-maa-080711/</loc>
		<lastmod>2011-07-08T07:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-msd-names-new-president-080711/</loc>
		<lastmod>2011-07-08T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-japan-astellas-pharma-amend-caduet-combination-tablets-deal-080711/</loc>
		<lastmod>2011-07-08T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/achillion-pharma-commences-dosing-in-phase-1-hcv-drug-trial-110711/</loc>
		<lastmod>2011-07-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sagent-pharma-signs-development-agreement-with-chongqing-lummy-110711/</loc>
		<lastmod>2011-07-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/isogenica-establishes-new-automation-facility-110711/</loc>
		<lastmod>2011-07-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunshine-biopharma-releases-cytotoxicity-study-results-110711/</loc>
		<lastmod>2011-07-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/global-pharm-purchases-tcm-herbal-pieces-processing-plant-110711/</loc>
		<lastmod>2011-07-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epo-revokes-bayer-patents-for-contraceptives-110711/</loc>
		<lastmod>2011-07-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eth-zurich-cloudbroker-select-ibm-cloud-computing-110711/</loc>
		<lastmod>2011-07-11T00:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onconova-symbio-in-rigosertib-development-pact-110711/</loc>
		<lastmod>2011-07-11T01:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-to-acquire-dermik-from-sanofi-110711/</loc>
		<lastmod>2011-07-11T01:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-genzyme-release-care-ms-i-phase-3-trial-results-110711/</loc>
		<lastmod>2011-07-11T02:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-app-pharma-analgesic-injection-110711/</loc>
		<lastmod>2011-07-11T03:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tpi-to-start-test-runs-at-jcm-manufacturing-plant-110711/</loc>
		<lastmod>2011-07-11T04:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/life-technologies-establishes-idc-in-india-110711/</loc>
		<lastmod>2011-07-11T06:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orchid-chemicals-pharma-receives-closure-notice-for-gmp-issues-110711/</loc>
		<lastmod>2011-07-11T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson-to-commercialize-antares-oab-gel-in-us-canada-110711/</loc>
		<lastmod>2011-07-11T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vanda-selects-probiomed-to-commercialize-schizophrenia-drug-in-mexico-110711/</loc>
		<lastmod>2011-07-11T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arena-pharma-releases-phase-1-pah-drug-trial-results-120711/</loc>
		<lastmod>2011-07-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cerulean-pharma-starts-dosing-in-phase-2-nsclc-drug-trial-120711/</loc>
		<lastmod>2011-07-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acura-pharma-names-new-ceo-120711/</loc>
		<lastmod>2011-07-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phillips-purchases-medisize-140711/</loc>
		<lastmod>2011-07-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/micromet-amgen-sign-bite-antibodies-pact-120711/</loc>
		<lastmod>2011-07-11T23:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/monosol-rx-seeks-new-partners-for-zuplenz-oral-soluble-film-120711/</loc>
		<lastmod>2011-07-12T01:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advaxis-concludes-patient-recruitment-in-cin-low-dose-cohort-120711/</loc>
		<lastmod>2011-07-12T01:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zynx-health-to-offer-prime-a-pump-to-yale-new-haven-health-system-120711/</loc>
		<lastmod>2011-07-12T02:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hikma-pharma-buys-minority-stake-in-hubei-haosun-120711/</loc>
		<lastmod>2011-07-12T03:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-allows-usana-to-manufacture-otc-drugs-120711/</loc>
		<lastmod>2011-07-12T03:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-issues-noa-for-prolor-ctp-platform-120711/</loc>
		<lastmod>2011-07-12T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3sbio-receives-sfda-approval-for-epiao-high-dose-formulation-120711/</loc>
		<lastmod>2011-07-12T05:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinapis-pharma-concludes-phase-i-stroke-drug-trial-120711/</loc>
		<lastmod>2011-07-12T06:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4sc-hcc-drug-receives-fda-orphan-drug-status-120711/</loc>
		<lastmod>2011-07-12T07:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/upsher-smith-rolls-out-trianex-005-120711/</loc>
		<lastmod>2011-07-12T07:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pinnaclife-releases-prenatal-care-package-120711/</loc>
		<lastmod>2011-07-12T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/university-of-houston-releases-wellmune-wgp-study-results-120711/</loc>
		<lastmod>2011-07-12T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen-salk-institute-renew-research-agreement-130711/</loc>
		<lastmod>2011-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/array-biopharma-selects-aslan-to-develop-arry-543-130711/</loc>
		<lastmod>2011-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza-to-take-over-arch-chemicals-130711/</loc>
		<lastmod>2011-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/datatrak-enters-into-multi-year-deal-with-biopharma-client-130711/</loc>
		<lastmod>2011-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-caliper-life-in-co-marketing-agreement-130711/</loc>
		<lastmod>2011-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-orion-in-breast-cancer-parkinsons-disease-drugs-marketing-deal-130711/</loc>
		<lastmod>2011-07-13T00:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-perifosine-gets-european-patent-130711/</loc>
		<lastmod>2011-07-13T01:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarantus-generex-to-co-develop-manf-based-therapeutic-130711/</loc>
		<lastmod>2011-07-13T02:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-glenmark-generic-cirrhosis-drug-130711/</loc>
		<lastmod>2011-07-13T04:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-nod-to-dr-reddys-generic-fondaparinux-sodium-injection-anda-130711/</loc>
		<lastmod>2011-07-13T04:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-widens-licensing-pacts-with-indian-drug-manufacturers-130711/</loc>
		<lastmod>2011-07-13T04:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hybrigenics-releases-inecalcitol-preclinical-trial-results-130711/</loc>
		<lastmod>2011-07-13T05:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/newron-pharma-seeks-fda-approval-for-schizophrenia-drug-130711/</loc>
		<lastmod>2011-07-13T06:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-reveal-phase-2b-sarilumab-trial-results-130711/</loc>
		<lastmod>2011-07-13T07:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ivcc-scynexis-sign-agreement-130711/</loc>
		<lastmod>2011-07-13T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-dacogen-snda-130711/</loc>
		<lastmod>2011-07-13T08:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/michael-j-fox-foundation-grants-research-grant-for-impax-140711/</loc>
		<lastmod>2011-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-for-two-patent-applications-neuralstem-140711/</loc>
		<lastmod>2011-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli-lilly-hcl-to-establish-co-innovation-lab-in-singapore-140711/</loc>
		<lastmod>2011-07-13T21:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas-sues-sandoz-canada-over-generic-tacrolimus-140711/</loc>
		<lastmod>2011-07-14T01:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-mexico-widens-sucanon-distribution-network-140711/</loc>
		<lastmod>2011-07-14T02:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-pharma-acquires-japanese-drug-manufacturer-taiyo-140711/</loc>
		<lastmod>2011-07-14T03:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thallion-terminates-screening-in-shigatec-phase-ii-trial-140711/</loc>
		<lastmod>2011-07-14T04:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-to-investigate-roslin-gmp-quality-psc-140711/</loc>
		<lastmod>2011-07-14T05:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vela-protagen-sign-agreement-140711/</loc>
		<lastmod>2011-07-14T05:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/o2h-widens-agreement-with-heptares-140711/</loc>
		<lastmod>2011-07-14T06:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/unilife-starts-unifill-syringe-supply-to-sanofi-140711/</loc>
		<lastmod>2011-07-14T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adamis-pharma-vaccine-technology-receives-european-patent-140711/</loc>
		<lastmod>2011-07-14T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-orchid-mdd-drug-140711/</loc>
		<lastmod>2011-07-14T07:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pivotal-therapeutics-starts-vascazen-clinical-marketing-trials-140711/</loc>
		<lastmod>2011-07-14T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bptc-enters-into-consultancy-agreement-with-angel-biotechnology-140711/</loc>
		<lastmod>2011-07-14T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/healor-appoints-new-ceo-140711/</loc>
		<lastmod>2011-07-14T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pall-to-acquire-brazilian-partner-engefiltro-150711/</loc>
		<lastmod>2011-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aptalis-pharma-receives-fda-nod-for-zenpep-new-strength-150711/</loc>
		<lastmod>2011-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/granules-india-omnichem-to-establish-drug-manufacturing-plant-150711/</loc>
		<lastmod>2011-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-allows-amgen-to-market-xgeva-in-eu-150711/</loc>
		<lastmod>2011-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-receives-odac-recommendation-for-adcetris-approval-150711/</loc>
		<lastmod>2011-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/life-technologies-develops-new-drug-delivery-technology-150711/</loc>
		<lastmod>2011-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-hgs-benlysta-get-european-approval-150711/</loc>
		<lastmod>2011-07-15T00:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icon-takes-over-firecrest-clinical-150711/</loc>
		<lastmod>2011-07-15T00:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cilag-acquires-jb-chemicals-otc-brands-150711/</loc>
		<lastmod>2011-07-15T01:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarin-starts-phase-1-bmn-673-trial-150711/</loc>
		<lastmod>2011-07-15T02:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical-astellas-pharma-sign-licensing-deals-150711/</loc>
		<lastmod>2011-07-15T03:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emd-serono-designates-new-president-150711/</loc>
		<lastmod>2011-07-15T04:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-cancer-drug-phase-iii-trial-meets-primary-endpoint-150711/</loc>
		<lastmod>2011-07-15T05:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-awards-patent-to-arch-biopartners-biofilm-inhibitor-150711/</loc>
		<lastmod>2011-07-15T05:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-novo-nordisk-prefilled-insulin-pen-150711/</loc>
		<lastmod>2011-07-15T07:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-pharma-to-buy-ortho-dermatologics-150711/</loc>
		<lastmod>2011-07-15T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/romaco-installs-three-blister-lines-at-cpm-contractpharma-180711/</loc>
		<lastmod>2011-07-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-schering-plough-deploys-mcc-presster-tablet-press-180711/</loc>
		<lastmod>2011-07-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aicuris-releases-phase-ii-genital-herpes-drug-trial-results-180711/</loc>
		<lastmod>2011-07-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-ships-influenza-vaccine-to-us-180711/</loc>
		<lastmod>2011-07-18T00:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-resolves-patent-dispute-with-amgen-180711/</loc>
		<lastmod>2011-07-18T02:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/leo-pharma-in-research-pact-with-scripps-research-institute-180711/</loc>
		<lastmod>2011-07-18T02:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest-pierre-fabre-release-mdd-drug-phase-iii-trial-results-180711/</loc>
		<lastmod>2011-07-18T02:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seek-concludes-hiv-v-vaccine-phase-ibii-trial-180711/</loc>
		<lastmod>2011-07-18T03:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark-duodenal-ulcer-drug-gets-fda-approval-180711/</loc>
		<lastmod>2011-07-18T03:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gw-pharma-rolls-out-sativex-in-denmark-180711/</loc>
		<lastmod>2011-07-18T05:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qrxpharma-starts-moxduo-ir-nda-filing-procedure-with-fda-180711/</loc>
		<lastmod>2011-07-18T06:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimmune-submits-sbla-for-quadrivalent-nasal-spray-180711/</loc>
		<lastmod>2011-07-18T06:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synairgen-to-receive-japanese-patent-for-inhaled-ifn-beta-180711/</loc>
		<lastmod>2011-07-18T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cyclacel-daiichi-amend-cancer-drug-licensing-deal-180711/</loc>
		<lastmod>2011-07-18T07:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest-labs-q1-net-revenues-up-190711/</loc>
		<lastmod>2011-07-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/womens-choice-pharma-introduces-procort-in-us-190711/</loc>
		<lastmod>2011-07-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synteract-names-new-ceo-190711/</loc>
		<lastmod>2011-07-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intelsius-partners-with-ati-200711/</loc>
		<lastmod>2011-07-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sigma-life-science-launches-targeted-integration-kit-190711/</loc>
		<lastmod>2011-07-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-ulcerative-colitis-drug-gets-fda-nod-190711/</loc>
		<lastmod>2011-07-19T00:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/hitachi-cegedim-to-offer-crm-solutions-in-apac-region-190711/</loc>
		<lastmod>2011-07-19T00:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-ships-influenza-vaccine-to-us-190711/</loc>
		<lastmod>2011-07-19T01:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-rolls-out-breast-cancer-drug-in-japan-190711/</loc>
		<lastmod>2011-07-19T02:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-new-vaccine-formulation-for-influenza-190711/</loc>
		<lastmod>2011-07-19T02:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lannett-gets-fda-nod-for-anti-obesity-drug-190711/</loc>
		<lastmod>2011-07-19T03:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hong-kong-asks-gsk-to-call-back-augmentin-375-mg-tablets-190711/</loc>
		<lastmod>2011-07-19T05:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biofocus-collaborates-with-imd-190711/</loc>
		<lastmod>2011-07-19T06:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sherpa-opens-new-cgmp-production-facility-in-san-diego-190711/</loc>
		<lastmod>2011-07-19T06:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cellceutix-gets-notice-of-acceptance-for-cancer-drug-trial-190711/</loc>
		<lastmod>2011-07-19T06:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/white-coat-nutrition-launches-nutritional-vmp-system-190711/</loc>
		<lastmod>2011-07-19T07:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/youngevity-names-new-president-190711/</loc>
		<lastmod>2011-07-19T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nektar-receives-comp-positive-opinion-for-ovarian-cancer-drug-190711/</loc>
		<lastmod>2011-07-19T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apricus-seeks-marketing-authorization-for-ed-drug-in-switzerland-200711/</loc>
		<lastmod>2011-07-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto-grants-new-patent-to-hemispherx-200711/</loc>
		<lastmod>2011-07-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow-chemical-mitsui-sign-jv-210711/</loc>
		<lastmod>2011-07-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-introduces-lixiana-in-japan-200711/</loc>
		<lastmod>2011-07-19T23:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/robinson-pharma-obtains-usp-approval-for-four-tablets-200711/</loc>
		<lastmod>2011-07-20T00:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/battelle-acquires-instem-provantis-submit-preclinical-softwares-200711/</loc>
		<lastmod>2011-07-20T01:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cel-sci-widens-licensing-deal-with-teva-200711/</loc>
		<lastmod>2011-07-20T01:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nhlbi-funds-p2d-bioscience-to-develop-drugs-for-lung-diseases-200711/</loc>
		<lastmod>2011-07-20T02:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-pays-milestone-to-rib-x-200711/</loc>
		<lastmod>2011-07-20T03:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos-initiates-cachexia-drug-phase-i-proof-of-mechanism-trial-200711/</loc>
		<lastmod>2011-07-20T03:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immune-pharma-selects-lonza-to-produce-bertilimumab-200711/</loc>
		<lastmod>2011-07-20T05:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sun-pharma-generic-bph-drug-gets-fda-approval-200711/</loc>
		<lastmod>2011-07-20T06:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/unilife-starts-unifill-syringe-supply-to-pharma-firm-200711/</loc>
		<lastmod>2011-07-20T06:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icon-q2-revenue-rises-200711/</loc>
		<lastmod>2011-07-20T07:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/millennium-submits-mm-drug-snda-to-fda-200711/</loc>
		<lastmod>2011-07-20T08:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-pharma-releases-hiv-drug-clinical-findings-200711/</loc>
		<lastmod>2011-07-20T08:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunomedics-receives-additional-patent-for-pegylation-method-200711/</loc>
		<lastmod>2011-07-20T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-q2-net-sales-up-27-200711/</loc>
		<lastmod>2011-07-20T08:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/supergen-acquires-astex-210711/</loc>
		<lastmod>2011-07-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regulus-identifies-third-microrna-target-in-gsk-pact-210711/</loc>
		<lastmod>2011-07-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anomatic-to-establish-new-anodizing-facility-in-ohio-210711/</loc>
		<lastmod>2011-07-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-lannet-generic-obesity-drug-210711/</loc>
		<lastmod>2011-07-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/coridon-enters-into-collaboration-for-ebv-project-research-210711/</loc>
		<lastmod>2011-07-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/swiss-researchers-deploy-roche-cellavista-system-210711/</loc>
		<lastmod>2011-07-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-roche-widens-hcv-drug-collaboration-210711/</loc>
		<lastmod>2011-07-21T00:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ahm-appoints-new-ceo-210711/</loc>
		<lastmod>2011-07-21T00:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-acs-drug-gets-fda-nod-210711/</loc>
		<lastmod>2011-07-21T00:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actavis-ships-oxymorphone-hydrochloride-er-tablets-210711/</loc>
		<lastmod>2011-07-21T01:42:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->